{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T11:31:39Z","timestamp":1789558299495,"version":"build-2803163510"},"reference-count":220,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,1,20]],"date-time":"2024-01-20T00:00:00Z","timestamp":1705708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,1,20]],"date-time":"2024-01-20T00:00:00Z","timestamp":1705708800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Guangdong Province National key research and development project","award":["2021YFA0910200"],"award-info":[{"award-number":["2021YFA0910200"]}]},{"name":"Guangdong Province key research and development project","award":["2022B1111070006"],"award-info":[{"award-number":["2022B1111070006"]}]},{"name":"Innovation Development Project of Guangdong Academy of Sciences","award":["2020GDASYL20200102003"],"award-info":[{"award-number":["2020GDASYL20200102003"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Appl Microbiol Biotechnol"],"published-print":{"date-parts":[[2024,12]]},"abstract":"\n Abstract<\/jats:title>\n Cardiometabolic disease (CMD) encompasses a range of diseases such as hypertension, atherosclerosis, heart failure, obesity, and type 2 diabetes. Recent findings about CMD\u2019s interaction with gut microbiota have broadened our understanding of how diet and nutrition drive microbes to influence CMD. However, the translation of basic research into the clinic has not been smooth, and dietary nutrition and probiotic supplementation have yet to show significant evidence of the therapeutic benefits of CMD. In addition, the published reviews do not suggest the core microbiota or metabolite classes that influence CMD, and systematically elucidate the causal relationship between host disease phenotypes-microbiome. The aim of this review is to highlight the complex interaction of the gut microbiota and their metabolites with CMD progression and to further centralize and conceptualize the mechanisms of action between microbial and host disease phenotypes. We also discuss the potential of targeting modulations of gut microbes and metabolites as new targets for prevention and treatment of CMD, including the use of emerging technologies such as fecal microbiota transplantation and nanomedicine.<\/jats:p>\n <\/jats:sec>\n \n Key points<\/jats:title>\n \n \u2022\n To highlight the complex interaction of the gut microbiota and their metabolites with CMD progression and to further centralize and conceptualize the mechanisms of action between microbial and host disease phenotypes<\/jats:italic>\n .\n <\/jats:p>\n \n \u2022\n We also discuss the potential of targeting modulations of gut microbes and metabolites as new targets for prevention and treatment of CMD, including the use of emerging technologies such as FMT and nanomedicine<\/jats:italic>\n .\n <\/jats:p>\n \n \u2022\n Our study provides insight into identification-specific microbiomes and metabolites involved in CMD, and microbial-host changes and physiological factors as disease phenotypes develop, which will help to map the microbiome individually and capture pathogenic mechanisms as a whole<\/jats:italic>\n .\n <\/jats:p>\n <\/jats:sec>\n \n Graphical Abstract<\/jats:title>\n <\/jats:sec>","DOI":"10.1007\/s00253-024-13007-7","type":"journal-article","created":{"date-parts":[[2024,1,20]],"date-time":"2024-01-20T02:02:41Z","timestamp":1705716161000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Therapeutic applications of gut microbes in cardiometabolic diseases: current state and perspectives"],"prefix":"10.1007","volume":"108","author":[{"given":"Lin","family":"Yuan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moutong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qihui","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jumei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinqiang","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6503-359X","authenticated-orcid":false,"given":"Qingping","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,1,20]]},"reference":[{"issue":"6","key":"13007_CR1","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.chom.2018.05.003","volume":"23","author":"A Agus","year":"2018","unstructured":"Agus A, Planchais J, Sokol H (2018) Gut microbiota regulation of tryptophan metabolism in health and disease. Cell Host Microbe 23(6):716\u2013724","journal-title":"Cell Host Microbe"},{"key":"13007_CR2","doi-asserted-by":"publisher","unstructured":"Alhabeeb H, AlFaiz A, Kutbi E, AlShahrani D, Alsuhail A, AlRajhi S, Alotaibi N, Alotaibi K, AlAmri S, Alghamdi S, AlJohani N (2021) Gut hormones in health and obesity: the upcoming role of short chain fatty acids. Nutrients 13(2) https:\/\/doi.org\/10.3390\/nu13020481","DOI":"10.3390\/nu13020481"},{"issue":"1","key":"13007_CR3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13073-021-00856-4","volume":"13","author":"C Alvarez-Silva","year":"2021","unstructured":"Alvarez-Silva C, Kashani A, Hansen TH, Pinna NK, Anjana RM, Dutta A, Saxena S, St\u00f8y J, Kampmann U, Nielsen T (2021) Trans-ethnic gut microbiota signatures of type 2 diabetes in Denmark and India. Genome Med 13(1):1\u201313","journal-title":"Genome Med"},{"issue":"10","key":"13007_CR4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11892-018-1048-7","volume":"18","author":"Z Arany","year":"2018","unstructured":"Arany Z, Neinast M (2018) Branched chain amino acids in metabolic disease. Curr Diabetes Rep 18(10):1\u20138","journal-title":"Curr Diabetes Rep"},{"issue":"2","key":"13007_CR5","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1007\/s40199-019-00302-2","volume":"27","author":"E Ardeshirlarijani","year":"2019","unstructured":"Ardeshirlarijani E, Tabatabaei-Malazy O, Mohseni S, Qorbani M, Larijani B, Baradar Jalili R (2019) Effect of probiotics supplementation on glucose and oxidative stress in type 2 diabetes mellitus: a meta-analysis of randomized trials. Daru 27(2):827\u2013837","journal-title":"Daru"},{"issue":"4","key":"13007_CR6","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1002\/eji.201646879","volume":"48","author":"S Ascher","year":"2018","unstructured":"Ascher S, Reinhardt C (2018) The gut microbiota: an emerging risk factor for cardiovascular and cerebrovascular disease. Eur J Immunol 48(4):564\u2013575","journal-title":"Eur J Immunol"},{"key":"13007_CR7","doi-asserted-by":"publisher","unstructured":"Aydin O, Nieuwdorp M, Gerdes V (2018) The gut microbiome as a target for the treatment of type 2 diabetes. Curr Diabetes Rep 18(8) https:\/\/doi.org\/10.1007\/s11892-018-1020-6","DOI":"10.1007\/s11892-018-1020-6"},{"issue":"undefined","key":"13007_CR8","doi-asserted-by":"publisher","first-page":"9478630","DOI":"10.1155\/2018\/9478630","volume":"2018","author":"M Azad","year":"2018","unstructured":"Azad M, Kalam A, Sarker M, Li T, Yin J (2018) Probiotic species in the modulation of gut microbiota: an overview. Biomed Res Int 2018(undefined):9478630. https:\/\/doi.org\/10.1155\/2018\/9478630","journal-title":"Biomed Res Int"},{"key":"13007_CR9","doi-asserted-by":"publisher","unstructured":"Babu S, Jayaraman S (2020) An update on beta-sitosterol: a potential herbal nutraceutical for diabetic management. Biomed Pharmacother 131 https:\/\/doi.org\/10.1016\/j.biopha.2020.110702","DOI":"10.1016\/j.biopha.2020.110702"},{"issue":"44","key":"13007_CR10","doi-asserted-by":"crossref","first-page":"15718","DOI":"10.1073\/pnas.0407076101","volume":"101","author":"F B\u00e4ckhed","year":"2004","unstructured":"B\u00e4ckhed F, Ding H, Wang T, Hooper LV, Koh GY, Nagy A, Semenkovich CF, Gordon JI (2004) The gut microbiota as an environmental factor that regulates fat storage. Proc Natl Acad Sci 101(44):15718\u201315723","journal-title":"Proc Natl Acad Sci"},{"issue":"3","key":"13007_CR11","doi-asserted-by":"crossref","first-page":"671","DOI":"10.3390\/nu11030671","volume":"11","author":"E Barengolts","year":"2019","unstructured":"Barengolts E, Smith ED, Reutrakul S, Tonucci L, Anothaisintawee T (2019) The effect of probiotic yogurt on glycemic control in type 2 diabetes or obesity: a meta-analysis of nine randomized controlled trials. Nutrients 11(3):671","journal-title":"Nutrients"},{"key":"13007_CR12","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.1136\/gutjnl-2021-325753","volume":"71","author":"E Belda","year":"2022","unstructured":"Belda E, Voland L, Tremaroli V, Falony G, Adriouch S, Assmann KE, Prifti E, Aron-Wisnewsky J, Deb\u00e9dat J, Le Roy T (2022) Impairment of gut microbial biotin metabolism and host biotin status in severe obesity: effect of biotin and prebiotic supplementation on improved metabolism. Gut 71:2463\u20132480","journal-title":"Gut"},{"issue":"1","key":"13007_CR13","doi-asserted-by":"publisher","first-page":"4728","DOI":"10.1038\/s41467-021-25056-x","volume":"12","author":"T Blasco","year":"2021","unstructured":"Blasco T, P\u00e9rez-Burillo S, Balzerani F, Hinojosa-Nogueira D, Lerma-Aguilera A, Pastoriza S, Cendoya X, Rubio \u00c1, Gosalbes M, Jim\u00e9nez-Hern\u00e1ndez N, Pilar Francino M, Apaolaza I, Rufi\u00e1n-Henares J, Planes F (2021) An extended reconstruction of human gut microbiota metabolism of dietary compounds. Nat Commun 12(1):4728. https:\/\/doi.org\/10.1038\/s41467-021-25056-x","journal-title":"Nat Commun"},{"issue":"9","key":"13007_CR14","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.tcb.2019.05.005","volume":"29","author":"S Bose","year":"2019","unstructured":"Bose S, Ramesh V, Locasale JW (2019) Acetate metabolism in physiology, cancer, and beyond. Trends Cell Biol 29(9):695\u2013703","journal-title":"Trends Cell Biol"},{"issue":"2","key":"13007_CR15","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1097\/mol.0000000000000154","volume":"26","author":"E Brandsma","year":"2015","unstructured":"Brandsma E, Houben T, Fu J, Shiri-Sverdlov R, Hofker MH (2015) The immunity-diet-microbiota axis in the development of metabolic syndrome. Curr Opin Lipidol 26(2):73\u201381. https:\/\/doi.org\/10.1097\/mol.0000000000000154","journal-title":"Curr Opin Lipidol"},{"key":"13007_CR16","doi-asserted-by":"publisher","unstructured":"Calderon-Perez L, Gosalbes MJ, Yuste S, Valls RM, Pedret A, Llaurado E, Jimenez-Hernandez N, Artacho A, Pla-Paga L, Companys J, Ludwig I, Romero M-P, Rubio L, Sola R (2020) Gut metagenomic and short chain fatty acids signature in hypertension: a cross-sectional study. Sci Rep-UK 10(1) https:\/\/doi.org\/10.1038\/s41598-020-63475-w","DOI":"10.1038\/s41598-020-63475-w"},{"issue":"1","key":"13007_CR17","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3390\/metabo12010065","volume":"12","author":"C Callender","year":"2022","unstructured":"Callender C, Attaye I, Nieuwdorp M (2022) The interaction between the gut microbiome and bile acids in cardiometabolic diseases. Metabolites 12(1):65","journal-title":"Metabolites"},{"issue":"8","key":"13007_CR18","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1007\/s11883-022-01040-8","volume":"24","author":"S Cao","year":"2022","unstructured":"Cao S, Weaver CM (2022) Bioactives in the food supply: effects on CVD health. Curr Atheroscler Rep 24(8):655\u2013661. https:\/\/doi.org\/10.1007\/s11883-022-01040-8","journal-title":"Curr Atheroscler Rep"},{"issue":"5","key":"13007_CR19","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1016\/j.jvs.2017.09.029","volume":"68","author":"CA Cason","year":"2018","unstructured":"Cason CA, Dolan KT, Sharma G, Tao M, Kulkarni R, Helenowski IB, Doane BM, Avram MJ, McDermott MM, Chang EB (2018) Plasma microbiome-modulated indole-and phenyl-derived metabolites associate with advanced atherosclerosis and postoperative outcomes. J Vasc Surg 68(5):1552-1562.e7","journal-title":"J Vasc Surg"},{"key":"13007_CR20","doi-asserted-by":"publisher","unstructured":"Catar R, Chen L, Zhao H, Wu D, Kamhieh-Milz J, Luecht C, Zickler D, Krug AW, Ziegler CG, Morawietz H, Witowski J (2022) Native and oxidized low-density lipoproteins increase the expression of the LDL receptor and the LOX-1 receptor, respectively, in arterial endothelial cells. Cells 11(2) https:\/\/doi.org\/10.3390\/cells11020204","DOI":"10.3390\/cells11020204"},{"issue":"12","key":"13007_CR21","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/s41575-018-0058-x","volume":"15","author":"C Caussy","year":"2018","unstructured":"Caussy C, Loomba R (2018) Gut microbiome, microbial metabolites and the development of NAFLD. Nat Rev Gastro Hepat 15(12):719\u2013720","journal-title":"Nat Rev Gastro Hepat"},{"key":"13007_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/s41569-022-00771-0","author":"RM Chakaroun","year":"2022","unstructured":"Chakaroun RM, Olsson LM, Backhed F (2022) The potential of tailoring the gut microbiome to prevent and treat cardiometabolic disease. Nat Rev Cardiol. https:\/\/doi.org\/10.1038\/s41569-022-00771-0","journal-title":"Nat Rev Cardiol"},{"issue":"4","key":"13007_CR23","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/s41569-022-00771-0","volume":"20","author":"RM Chakaroun","year":"2023","unstructured":"Chakaroun RM, Olsson LM, Backhed F (2023) The potential of tailoring the gut microbiome to prevent and treat cardiometabolic disease. Nat Rev Cardiol 20(4):217\u2013235. https:\/\/doi.org\/10.1038\/s41569-022-00771-0","journal-title":"Nat Rev Cardiol"},{"issue":"1","key":"13007_CR24","first-page":"1","volume":"6","author":"C-J Chang","year":"2015","unstructured":"Chang C-J, Lin C-S, Lu C-C, Martel J, Ko Y-F, Ojcius DM, Tseng S-F, Wu T-R, Chen Y-YM, Young JD (2015) Ganoderma lucidum reduces obesity in mice by modulating the composition of the gut microbiota. Nat Commun 6(1):1\u201319","journal-title":"Nat Commun"},{"key":"13007_CR25","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.cca.2020.04.037","volume":"507","author":"W Chen","year":"2020","unstructured":"Chen W, Zhang S, Wu J, Ye T, Wang S, Wang P, Xing D (2020a) Butyrate-producing bacteria and the gut-heart axis in atherosclerosis. Clin Chim Acta 507:236\u2013241","journal-title":"Clin Chim Acta"},{"issue":"6","key":"13007_CR26","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1042\/cs20200128","volume":"134","author":"X-F Chen","year":"2020","unstructured":"Chen X-F, Chen X, Tang X (2020b) Short-chain fatty acid, acylation and cardiovascular diseases. Clin Sci 134(6):657\u2013676. https:\/\/doi.org\/10.1042\/cs20200128","journal-title":"Clin Sci"},{"issue":"5","key":"13007_CR27","first-page":"1","volume":"22","author":"C Chi","year":"2020","unstructured":"Chi C, Li C, Wu D, Buys N, Wang W, Fan H, Sun J (2020) Effects of probiotics on patients with hypertension: a systematic review and meta-analysis. Curr Hypertens Rep 22(5):1\u20138","journal-title":"Curr Hypertens Rep"},{"issue":"2","key":"13007_CR28","doi-asserted-by":"crossref","first-page":"338","DOI":"10.3390\/nu11020338","volume":"11","author":"L Chiavaroli","year":"2019","unstructured":"Chiavaroli L, Viguiliouk E, Nishi SK, Blanco Mejia S, Raheli\u0107 D, Kahleov\u00e1 H, Salas-Salvad\u00f3 J, Kendall CW, Sievenpiper JL (2019) DASH dietary pattern and cardiometabolic outcomes: an umbrella review of systematic reviews and meta-analyses. Nutrients 11(2):338","journal-title":"Nutrients"},{"issue":"11","key":"13007_CR29","first-page":"e1112","volume":"94","author":"TH Chiu","year":"2020","unstructured":"Chiu TH, Chang H-R, Wang L-Y, Chang C-C, Lin M-N, Lin C-L (2020) Vegetarian diet and incidence of total, ischemic, and hemorrhagic stroke in 2 cohorts in Taiwan. Neurology 94(11):e1112\u2013e1121","journal-title":"Neurology"},{"issue":"1","key":"13007_CR30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-020-79139-8","volume":"11","author":"C Chong Nguyen","year":"2021","unstructured":"Chong Nguyen C, Duboc D, Rainteau D, Sokol H, Humbert L, Seksik P, Bellino A, Abdoul H, Bouazza N, Treluyer J-M (2021) Circulating bile acids concentration is predictive of coronary artery disease in human. Sci Rep-UK 11(1):1\u201310","journal-title":"Sci Rep-UK"},{"issue":"6","key":"13007_CR31","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1016\/j.cell.2012.01.035","volume":"148","author":"JC Clemente","year":"2012","unstructured":"Clemente JC, Ursell LK, Parfrey LW, Knight R (2012) The impact of the gut microbiota on human health: an integrative view. Cell 148(6):1258\u20131270","journal-title":"Cell"},{"issue":"4","key":"13007_CR32","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1093\/advances\/nmaa030","volume":"11","author":"J Companys","year":"2020","unstructured":"Companys J, Pla-Pag\u00e0 L, Calder\u00f3n-P\u00e9rez L, Llaurad\u00f3 E, Sol\u00e0 R, Pedret A, Valls RM (2020) Fermented dairy products, probiotic supplementation, and cardiometabolic diseases: a systematic review and meta-analysis. Adv Nutr 11(4):834\u2013863","journal-title":"Adv Nutr"},{"key":"13007_CR33","doi-asserted-by":"crossref","first-page":"721393","DOI":"10.3389\/fcvm.2021.721393","volume":"8","author":"TA Cookson","year":"2021","unstructured":"Cookson TA (2021) Bacterial-induced blood pressure reduction: mechanisms for the treatment of hypertension via the gut. Front Cardiovasc Med 8:721393","journal-title":"Front Cardiovasc Med"},{"issue":"1","key":"13007_CR34","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/s41430-018-0306-8","volume":"72","author":"I Cornejo-Pareja","year":"2019","unstructured":"Cornejo-Pareja I, Munoz-Garach A, Clemente-Postigo M, Tinahones FJ (2019) Importance of gut microbiota in obesity. Eur J Clin Nutr 72(1):26\u201337","journal-title":"Eur J Clin Nutr"},{"key":"13007_CR35","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.yfrne.2018.04.002","volume":"51","author":"S Cussotto","year":"2018","unstructured":"Cussotto S, Sandhu KV, Dinan TG, Cryan JF (2018) The neuroendocrinology of the microbiota-gut-brain axis: a behavioural perspective. Front Neuroendocrin 51:80\u2013101","journal-title":"Front Neuroendocrin"},{"issue":"8","key":"13007_CR36","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1038\/s41575-019-0157-3","volume":"16","author":"B Dalile","year":"2019","unstructured":"Dalile B, Van Oudenhove L, Vervliet B, Verbeke K (2019) The role of short-chain fatty acids in microbiota-gut-brain communication. Nat Rev Gastro Hepat 16(8):461\u2013478. https:\/\/doi.org\/10.1038\/s41575-019-0157-3","journal-title":"Nat Rev Gastro Hepat"},{"issue":"7484","key":"13007_CR37","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/nature12820","volume":"505","author":"LA David","year":"2014","unstructured":"David LA, Maurice CF, Carmody RN, Gootenberg DB, Button JE, Wolfe BE, Ling AV, Devlin AS, Varma Y, Fischbach MA (2014) Diet rapidly and reproducibly alters the human gut microbiome. Nature 505(7484):559\u2013563","journal-title":"Nature"},{"key":"13007_CR38","doi-asserted-by":"publisher","unstructured":"de Jonge PA, Wortelboer K, Scheithauer TPM, van den Born BJH, Zwinderman AH, Nobrega FL, Dutilh BE, Nieuwdorp M, Herrema H (2022) Gut virome profiling identifies a widespread bacteriophage family associated with metabolic syndrome. Nat Commun 13(1) https:\/\/doi.org\/10.1038\/s41467-022-31390-5","DOI":"10.1038\/s41467-022-31390-5"},{"issue":"1","key":"13007_CR39","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3390\/nu11010051","volume":"11","author":"J De la Cuesta-Zuluaga","year":"2018","unstructured":"De la Cuesta-Zuluaga J, Mueller NT, \u00c1lvarez-Quintero R, Vel\u00e1squez-Mej\u00eda EP, Sierra JA, Corrales-Agudelo V, Carmona JA, Abad JM, Escobar JS (2018) Higher fecal short-chain fatty acid levels are associated with gut microbiome dysbiosis, obesity, hypertension and cardiometabolic disease risk factors. Nutrients 11(1):51","journal-title":"Nutrients"},{"issue":"1","key":"13007_CR40","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.cmet.2016.06.013","volume":"24","author":"F De Vadder","year":"2016","unstructured":"De Vadder F, Kovatcheva-Datchary P, Zitoun C, Duchampt A, B\u00e4ckhed F, Mithieux G (2016) Microbiota-produced succinate improves glucose homeostasis via intestinal gluconeogenesis. Cell Metab 24(1):151\u2013157. https:\/\/doi.org\/10.1016\/j.cmet.2016.06.013","journal-title":"Cell Metab"},{"issue":"3","key":"13007_CR41","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.chom.2020.01.006","volume":"27","author":"EC Deehan","year":"2020","unstructured":"Deehan EC, Yang C, Perez-Mu\u00f1oz ME, Nguyen NK, Cheng CC, Triador L, Zhang Z, Bakal JA, Walter J (2020) Precision microbiome modulation with discrete dietary fiber structures directs short-chain fatty acid production. Cell Host Microbe 27(3):389-404.e6","journal-title":"Cell Host Microbe"},{"issue":"7","key":"13007_CR42","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1038\/s41591-019-0495-2","volume":"25","author":"C Depommier","year":"2019","unstructured":"Depommier C, Everard A, Druart C, Plovier H, Van Hul M, Vieira-Silva S, Falony G, Raes J, Maiter D, Delzenne NM (2019) Supplementation with Akkermansia muciniphila in overweight and obese human volunteers: a proof-of-concept exploratory study. Nat Med 25(7):1096\u20131103","journal-title":"Nat Med"},{"issue":"5","key":"13007_CR43","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/j.cell.2016.10.043","volume":"167","author":"MS Desai","year":"2016","unstructured":"Desai MS, Seekatz AM, Koropatkin NM, Kamada N, Hickey CA, Wolter M, Pudlo NA, Kitamoto S, Terrapon N, Muller A (2016) A dietary fiber-deprived gut microbiota degrades the colonic mucus barrier and enhances pathogen susceptibility. Cell 167(5):1339-1353.e21","journal-title":"Cell"},{"issue":"20","key":"13007_CR44","doi-asserted-by":"crossref","first-page":"12107","DOI":"10.3390\/ijms232012107","volume":"23","author":"L D\u00edez-Ricote","year":"2022","unstructured":"D\u00edez-Ricote L, Ruiz-Valderrey P, Mic\u00f3 V, Blanco R, Tom\u00e9-Carneiro J, D\u00e1valos A, Ordov\u00e1s JM, Daimiel L (2022) TMAO upregulates members of the miR-17\/92 cluster and impacts targets associated with atherosclerosis. Int J Mol Sci 23(20):12107","journal-title":"Int J Mol Sci"},{"issue":"11","key":"13007_CR45","doi-asserted-by":"crossref","first-page":"4887","DOI":"10.1039\/D0FO03266B","volume":"12","author":"L Ding","year":"2021","unstructured":"Ding L, Xu Z-J, Shi H-H, Xue C-H, Huang Q-R, Yanagita T, Wang Y-M, Zhang T-T (2021) Sterol sulfate alleviates atherosclerosis via mediating hepatic cholesterol metabolism in ApoE\u2212\/\u2212 mice. Food Funct 12(11):4887\u20134896","journal-title":"Food Funct"},{"issue":"7682","key":"13007_CR46","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/nature24661","volume":"551","author":"D Dodd","year":"2017","unstructured":"Dodd D, Spitzer MH, Van Treuren W, Merrill BD, Hryckowian AJ, Higginbottom SK, Le A, Cowan TM, Nolan GP, Fischbach MA (2017) A gut bacterial pathway metabolizes aromatic amino acids into nine circulating metabolites. Nature 551(7682):648\u2013652","journal-title":"Nature"},{"issue":"3","key":"13007_CR47","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1159\/000499028","volume":"74","author":"Y Dong","year":"2019","unstructured":"Dong Y, Xu M, Chen L, Bhochhibhoya A (2019) Probiotic foods and supplements interventions for metabolic syndromes: a systematic review and meta-analysis of recent clinical trials. Ann Nutr Metab 74(3):224\u2013241","journal-title":"Ann Nutr Metab"},{"key":"13007_CR48","doi-asserted-by":"publisher","unstructured":"Du L, Li Q, Yi H, Kuang T, Tang Y, Fan G (2022) Gut microbiota-derived metabolites as key actors in type 2 diabetes mellitus. Biomed Pharmacother 149 https:\/\/doi.org\/10.1016\/j.biopha.2022.112839","DOI":"10.1016\/j.biopha.2022.112839"},{"key":"13007_CR49","doi-asserted-by":"publisher","unstructured":"Estruch R, Ros E, Salas-Salvado J, Covas MI, Corella D, Aros F, Gomez-Gracia E, Ruiz-Gutierrez V, Fiol M, Lapetra J, Lamuela-Raventos RM, Serra-Majem L, Pinto X, Basora J, Munoz MA, Sorli JV, Martinez JA, Fito M, Gea A, Hernan MA, Martinez-Gonzalez MA, Investigators PS (2018) Primary prevention of cardiovascular disease with a mediterranean diet supplemented with extra-virgin olive oil or nuts. New Engl J Med 378(25) https:\/\/doi.org\/10.1056\/NEJMoa1800389","DOI":"10.1056\/NEJMoa1800389"},{"issue":"8","key":"13007_CR50","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.3390\/biom12081120","volume":"12","author":"C Fang","year":"2022","unstructured":"Fang C, Zuo K, Jiao K, Zhu X, Fu Y, Zhong J, Xu L, Yang X (2022) PAGln, an atrial fibrillation-linked gut microbial metabolite, acts as a promoter of atrial myocyte injury. Biomolecules 12(8):1120","journal-title":"Biomolecules"},{"key":"13007_CR51","doi-asserted-by":"publisher","first-page":"939571","DOI":"10.3389\/fnut.2022.939571","volume":"9","author":"W Feng","year":"2022","unstructured":"Feng W, Liu J, Cheng H, Zhang D, Tan Y, Peng C (2022) Dietary compounds in modulation of gut microbiota-derived metabolites. Front Nutr 9:939571. https:\/\/doi.org\/10.3389\/fnut.2022.939571","journal-title":"Front Nutr"},{"key":"13007_CR52","doi-asserted-by":"publisher","unstructured":"Feng Y, Huang Y, Wang Y, Wang P, Song H, Wang F (2019) Antibiotics induced intestinal tight junction barrier dysfunction is associated with microbiota dysbiosis, activated NLRP3 inflammasome and autophagy. Plos One 14(6) https:\/\/doi.org\/10.1371\/journal.pone.0218384","DOI":"10.1371\/journal.pone.0218384"},{"issue":"5","key":"13007_CR53","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1093\/advances\/nmaa041","volume":"11","author":"CD Filippou","year":"2020","unstructured":"Filippou CD, Tsioufis CP, Thomopoulos CG, Mihas CC, Dimitriadis KS, Sotiropoulou LI, Chrysochoou CA, Nihoyannopoulos PI, Tousoulis DM (2020) Dietary approaches to stop hypertension (DASH) diet and blood pressure reduction in adults with and without hypertension: a systematic review and meta-analysis of randomized controlled trials. Adv Nutr 11(5):1150\u20131160","journal-title":"Adv Nutr"},{"issue":"9","key":"13007_CR54","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1038\/s42255-020-0188-7","volume":"2","author":"J Frampton","year":"2020","unstructured":"Frampton J, Murphy KG, Frost G, Chambers ES (2020) Short-chain fatty acids as potential regulators of skeletal muscle metabolism and function. Nat Metab 2(9):840\u2013848. https:\/\/doi.org\/10.1038\/s42255-020-0188-7","journal-title":"Nat Metab"},{"key":"13007_CR55","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.biomaterials.2018.06.015","volume":"178","author":"J Gan","year":"2018","unstructured":"Gan J, Dou Y, Li Y, Wang Z, Wang L, Liu S, Li Q, Yu H, Liu C, Han C (2018) Producing anti-inflammatory macrophages by nanoparticle-triggered clustering of mannose receptors. Biomaterials 178:95\u2013108","journal-title":"Biomaterials"},{"key":"13007_CR56","doi-asserted-by":"publisher","unstructured":"Gao R, Meng X, Xue Y, Mao M, Liu Y, Tian X, Sui B, Li X, Zhang P (2022) Bile acids-gut microbiota crosstalk contributes to the improvement of type 2 diabetes mellitus. Front Pharmacol 13 https:\/\/doi.org\/10.3389\/fphar.2022.1027212","DOI":"10.3389\/fphar.2022.1027212"},{"key":"13007_CR57","doi-asserted-by":"crossref","first-page":"890","DOI":"10.3389\/fmicb.2018.00890","volume":"9","author":"I Garcia-Mantrana","year":"2018","unstructured":"Garcia-Mantrana I, Selma-Royo M, Alcantara C, Collado MC (2018) Shifts on gut microbiota associated to mediterranean diet adherence and specific dietary intakes on general adult population. Front Microbiol 9:890","journal-title":"Front Microbiol"},{"issue":"1","key":"13007_CR58","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1093\/advances\/nmz064","volume":"11","author":"X Ge","year":"2020","unstructured":"Ge X, Zheng L, Zhuang R, Yu P, Xu Z, Liu G, Xi X, Zhou X, Fan H (2020) The gut microbial metabolite trimethylamine N-oxide and hypertension risk: a systematic review and dose\u2013response meta-analysis. Adv Nutr 11(1):66\u201376","journal-title":"Adv Nutr"},{"key":"13007_CR59","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.biopha.2017.11.016","volume":"97","author":"J Geng","year":"2018","unstructured":"Geng J, Yang C, Wang B, Zhang X, Hu T, Gu Y, Li J (2018) Trimethylamine N-oxide promotes atherosclerosis via CD36-dependent MAPK\/JNK pathway. Biomed Pharmacother 97:941\u2013947","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"13007_CR60","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1161\/CIRCGENETICS.114.000219","volume":"8","author":"JL Griffin","year":"2015","unstructured":"Griffin JL, Wang X, Stanley E (2015) Does our gut microbiome predict cardiovascular risk? A review of the evidence from metabolomics. Circ-Cardiovasc Gene 8(1):187\u2013191","journal-title":"Circ-Cardiovasc Gene"},{"issue":"11","key":"13007_CR61","doi-asserted-by":"crossref","first-page":"3131","DOI":"10.1016\/j.numecd.2021.06.024","volume":"31","author":"M Guo","year":"2021","unstructured":"Guo M, Fan X, Tuerhongjiang G, Wang C, Wu H, Lou B, Wu Y, Yuan Z, She J (2021) Targeted metabolomic analysis of plasma fatty acids in acute myocardial infarction in young adults. Nutr Metab Cardiovas 31(11):3131\u20133141","journal-title":"Nutr Metab Cardiovas"},{"issue":"20","key":"13007_CR62","doi-asserted-by":"publisher","first-page":"5945","DOI":"10.1021\/acs.jafc.1c07851","volume":"70","author":"ZN Guo","year":"2022","unstructured":"Guo ZN, Pan JJ, Zhu HY, Chen ZY (2022) Metabolites of gut microbiota and possible implication in development of diabetes mellitus. J Agric Food Chem 70(20):5945\u20135960. https:\/\/doi.org\/10.1021\/acs.jafc.1c07851","journal-title":"J Agric Food Chem"},{"issue":"6","key":"13007_CR63","doi-asserted-by":"crossref","first-page":"906","DOI":"10.3390\/antiox10060906","volume":"10","author":"FM Gutierrez-Mariscal","year":"2021","unstructured":"Gutierrez-Mariscal FM, de la Cruz-Ares S, Torres-Pe\u00f1a JD, Alcal\u00e1-Diaz JF, Yubero-Serrano EM, L\u00f3pez-Miranda J (2021) Coenzyme q10 and cardiovascular diseases. Antioxidants 10(6):906","journal-title":"Antioxidants"},{"issue":"4","key":"13007_CR64","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1080\/10408398.2018.1545218","volume":"60","author":"A Hadi","year":"2020","unstructured":"Hadi A, Alizadeh K, Hajianfar H, Mohammadi H, Miraghajani M (2020) Efficacy of synbiotic supplementation in obesity treatment: a systematic review and meta-analysis of clinical trials. Crit Rev Food Sci 60(4):584\u2013596","journal-title":"Crit Rev Food Sci"},{"issue":"6","key":"13007_CR65","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1093\/eurheartj\/ehab644","volume":"43","author":"A Haghikia","year":"2022","unstructured":"Haghikia A, Zimmermann F, Schumann P, Jasina A, Roessler J, Schmidt D, Heinze P, Kaisler J, Nageswaran V, Aigner A, Ceglarek U, Cineus R, Hegazy AN, van der Vorst EPC, Doring Y, Strauch CM, Nemet I, Tremaroli V, Dwibedi C, Krankel N, Leistner DM, Heimesaat MM, Bereswill S, Rauch G, Seeland U, Soehnlein O, Mueller DN, Gold R, Baeckhed F, Hazen SL, Haghikia A, Landmesser U (2022) Propionate attenuates atherosclerosis by immune-dependent regulation of intestinal cholesterol metabolism. Eur Heart J 43(6):518\u2013533. https:\/\/doi.org\/10.1093\/eurheartj\/ehab644","journal-title":"Eur Heart J"},{"key":"13007_CR66","doi-asserted-by":"publisher","unstructured":"He GD, Liu XC, Lu AS, Feng YQ (2022) Association of choline intake with blood pressure and effects of its microbiota-dependent metabolite trimethylamine-N-oxide on hypertension. Cardiovasc Ther 2022 https:\/\/doi.org\/10.1155\/2022\/9512401","DOI":"10.1155\/2022\/9512401"},{"issue":"2","key":"13007_CR67","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.clnu.2017.02.015","volume":"37","author":"F Hendijani","year":"2018","unstructured":"Hendijani F, Akbari V (2018) Probiotic supplementation for management of cardiovascular risk factors in adults with type II diabetes: a systematic review and meta-analysis. Clin Nutr (edinburgh, Scotland) 37(2):532\u2013541","journal-title":"Clin Nutr (edinburgh, Scotland)"},{"issue":"5","key":"13007_CR68","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1111\/dom.12636","volume":"18","author":"RJ Hodge","year":"2016","unstructured":"Hodge RJ, Nunez DJ (2016) Therapeutic potential of Takeda-G-protein-receptor-5 (TGR5) agonists. Hope or hype? Diabetes Obes Metab 18(5):439\u2013443. https:\/\/doi.org\/10.1111\/dom.12636","journal-title":"Diabetes Obes Metab"},{"key":"13007_CR69","doi-asserted-by":"publisher","unstructured":"Hoving LR, Katiraei S, Pronk A, Heijink M, Vonk KKD, Amghar-el Bouazzaoui F, Vermeulen R, Drinkwaard L, Giera M, van Harmelen V, van Dijk KW (2018) The prebiotic inulin modulates gut microbiota but does not ameliorate atherosclerosis in hypercholesterolemic APOE*3-Leiden. CETP mice. Sci Rep-UK 8https:\/\/doi.org\/10.1038\/s41598-018-34970-y","DOI":"10.1038\/s41598-018-34970-y"},{"issue":"6","key":"13007_CR70","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.chom.2019.05.001","volume":"25","author":"BB Hsu","year":"2019","unstructured":"Hsu BB, Gibson TE, Yeliseyev V, Liu Q, Lyon L, Bry L, Silver PA, Gerber GK (2019) Dynamic modulation of the gut microbiota and metabolome by bacteriophages in a mouse model. Cell Host Microbe 25(6):803\u2013814","journal-title":"Cell Host Microbe"},{"issue":"9","key":"13007_CR71","doi-asserted-by":"crossref","first-page":"3041","DOI":"10.3390\/nu13093041","volume":"13","author":"C-N Hsu","year":"2021","unstructured":"Hsu C-N, Hou C-Y, Lee C-T, Chang-Chien G-P, Lin S, Tain Y-L (2021) Maternal 3, 3-dimethyl-1-butanol therapy protects adult male rat offspring against hypertension programmed by perinatal TCDD exposure. Nutrients 13(9):3041","journal-title":"Nutrients"},{"issue":"45","key":"13007_CR72","doi-asserted-by":"publisher","first-page":"13533","DOI":"10.1021\/acs.jafc.1c05338","volume":"69","author":"S Hu","year":"2021","unstructured":"Hu S, Chen Y, Zhao S, Sun K, Luo L, Zeng L (2021) Ripened Pu-Erh tea improved the enterohepatic circulation in a circadian rhythm disorder mice model. J Agric Food Chem 69(45):13533\u201313545. https:\/\/doi.org\/10.1021\/acs.jafc.1c05338","journal-title":"J Agric Food Chem"},{"key":"13007_CR73","doi-asserted-by":"publisher","first-page":"101706","DOI":"10.1016\/j.arr.2022.101706","volume":"81","author":"T Hu","year":"2022","unstructured":"Hu T, Wu Q, Yao Q, Jiang K, Yu J, Tang Q (2022b) Short-chain fatty acid metabolism and multiple effects on cardiovascular diseases. Ageing Res Rev 81:101706\u2013101706. https:\/\/doi.org\/10.1016\/j.arr.2022.101706","journal-title":"Ageing Res Rev"},{"key":"13007_CR74","doi-asserted-by":"crossref","unstructured":"Hu T, Wu Q, Yao Q, Jiang K, Yu J, Tang Q (2022a) Short-chain fatty acid metabolism and multiple effects on cardiovascular diseases. Ageing Res Rev 101706","DOI":"10.1016\/j.arr.2022.101706"},{"issue":"4","key":"13007_CR75","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1165\/rcmb.2021-0414OC","volume":"66","author":"YH Huang","year":"2022","unstructured":"Huang YH, Lin FJ, Tang RD, Bao CL, Zhou QX, Ye KW, Shen Y, Liu CL, Hong C, Yang K, Tang HY, Wang J, Lu WJ, Wang T (2022b) Gut microbial metabolite trimethylamine N-oxide aggravates pulmonary hypertension. Am J Resp Cell Mol 66(4):452\u2013460. https:\/\/doi.org\/10.1165\/rcmb.2021-0414OC","journal-title":"Am J Resp Cell Mol"},{"key":"13007_CR76","unstructured":"Huang Y, Zhang H, Fan X, Wang J, Yin Y, Zhang Y, Shi K, Yu F (2022a) The role of gut microbiota and trimethylamine N-oxide in cardiovascular diseases. J Cardiovasc Transl 1\u20139"},{"issue":"5","key":"13007_CR77","doi-asserted-by":"crossref","first-page":"282","DOI":"10.3390\/metabo11050282","volume":"11","author":"J Huart","year":"2021","unstructured":"Huart J, Cirillo A, Taminiau B, Descy J, Saint-Remy A, Daube G, Krzesinski J-M, Melin P, De Tullio P, Jouret F (2021) Human stool metabolome differs upon 24 h blood pressure levels and blood pressure dipping status: a prospective longitudinal study. Metabolites 11(5):282","journal-title":"Metabolites"},{"issue":"2","key":"13007_CR78","doi-asserted-by":"crossref","first-page":"203","DOI":"10.3390\/nu10020203","volume":"10","author":"H Hug","year":"2018","unstructured":"Hug H, Mohajeri MH, La Fata G (2018) Toll-like receptors: regulators of the immune response in the human gut. Nutrients 10(2):203","journal-title":"Nutrients"},{"key":"13007_CR79","doi-asserted-by":"crossref","first-page":"108600","DOI":"10.1016\/j.jnutbio.2021.108600","volume":"91","author":"L Iglesias-Carres","year":"2021","unstructured":"Iglesias-Carres L, Hughes MD, Steele CN, Ponder MA, Davy KP, Neilson AP (2021) Use of dietary phytochemicals for inhibition of trimethylamine N-oxide formation. J Nutr Biochem 91:108600","journal-title":"J Nutr Biochem"},{"key":"13007_CR80","doi-asserted-by":"publisher","unstructured":"Innes JK, Calder PC (2020) Marine Omega-3 (N-3) fatty acids for cardiovascular health: an update for 2020. Int J Mol Sci 21(4) https:\/\/doi.org\/10.3390\/ijms21041362","DOI":"10.3390\/ijms21041362"},{"issue":"4","key":"13007_CR81","doi-asserted-by":"crossref","first-page":"H636","DOI":"10.1152\/ajpheart.00027.2022","volume":"322","author":"JA Ishimwe","year":"2022","unstructured":"Ishimwe JA, Dola T, Ertuglu LA, Kirabo A (2022) Bile acids and salt-sensitive hypertension: a role of the gut-liver axis. Am J Physiol-Heart C 322(4):H636\u2013H646","journal-title":"Am J Physiol-Heart C"},{"key":"13007_CR82","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.ahj.2021.01.006","volume":"234","author":"MZ Israr","year":"2021","unstructured":"Israr MZ, Bernieh D, Salzano A, Cassambai S, Yazaki Y, Heaney LM, Jones DJL, Ng LL, Suzuki T (2021) Association of gut-related metabolites with outcome in acute heart failure. Am Heart J 234:71\u201380. https:\/\/doi.org\/10.1016\/j.ahj.2021.01.006","journal-title":"Am Heart J"},{"issue":"1","key":"13007_CR83","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-017-02088-w","volume":"9","author":"MA Jackson","year":"2018","unstructured":"Jackson MA, Verdi S, Maxan M-E, Shin CM, Zierer J, Bowyer RC, Martin T, Williams FM, Menni C, Bell JT (2018) Gut microbiota associations with common diseases and prescription medications in a population-based cohort. Nat Commun 9(1):1\u20138","journal-title":"Nat Commun"},{"key":"13007_CR84","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.molmet.2018.01.005","volume":"9","author":"K Jadhav","year":"2018","unstructured":"Jadhav K, Xu Y, Xu Y, Li Y, Xu J, Zhu Y, Adorini L, Lee YK, Kasumov T, Yin L (2018) Reversal of metabolic disorders by pharmacological activation of bile acid receptors TGR5 and FXR. Mol Metab 9:131\u2013140","journal-title":"Mol Metab"},{"issue":"9","key":"13007_CR85","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1093\/cvr\/cvz091","volume":"115","author":"HA Jama","year":"2019","unstructured":"Jama HA, Beale A, Shihata WA, Marques FZ (2019a) The effect of diet on hypertensive pathology: is there a link via gut microbiota-driven immunometabolism? Cardiovasc Res 115(9):1435\u20131447","journal-title":"Cardiovasc Res"},{"issue":"2","key":"13007_CR86","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1097\/mnh.0000000000000476","volume":"28","author":"HA Jama","year":"2019","unstructured":"Jama HA, Kaye DM, Marques FZ (2019b) The gut microbiota and blood pressure in experimental models. Curr Opin Nephrol Hy 28(2):97\u2013104. https:\/\/doi.org\/10.1097\/mnh.0000000000000476","journal-title":"Curr Opin Nephrol Hy"},{"issue":"11","key":"13007_CR87","doi-asserted-by":"crossref","first-page":"14391","DOI":"10.1021\/acsnano.0c07258","volume":"14","author":"I Javed","year":"2020","unstructured":"Javed I, Cui X, Wang X, Mortimer M, Andrikopoulos N, Li Y, Davis TP, Zhao Y, Ke PC, Chen C (2020) Implications of the human gut\u2013brain and gut\u2013cancer axes for future nanomedicine. ACS Nano 14(11):14391\u201314416","journal-title":"ACS Nano"},{"issue":"28","key":"13007_CR88","doi-asserted-by":"publisher","first-page":"8569","DOI":"10.1021\/acs.jafc.2c02960","volume":"70","author":"X Jiang","year":"2022","unstructured":"Jiang X, Sun B, Zhou Z (2022) Preclinical studies of natural products targeting the gut microbiota: beneficial effects on diabetes. J Agric Food Chem 70(28):8569\u20138581. https:\/\/doi.org\/10.1021\/acs.jafc.2c02960","journal-title":"J Agric Food Chem"},{"issue":"5","key":"13007_CR89","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1007\/s13238-020-00785-9","volume":"12","author":"L Jin","year":"2021","unstructured":"Jin L, Shi X, Yang J, Zhao Y, Xue L, Xu L, Cai J (2021) Gut microbes in cardiovascular diseases and their potential therapeutic applications. Protein Cell 12(5):346\u2013359","journal-title":"Protein Cell"},{"issue":"10","key":"13007_CR90","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1093\/jn\/nxac147","volume":"152","author":"SA Johnson","year":"2022","unstructured":"Johnson SA, Weir TL (2022) Fresh take on the relationship between diet, gut microbiota, and atherosclerosis: a food-based approach with Brussels chicory. J Nutr 152(10):2181\u20132183","journal-title":"J Nutr"},{"issue":"2","key":"13007_CR91","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/nrcardio.2016.183","volume":"14","author":"AL Jonsson","year":"2017","unstructured":"Jonsson AL, B\u00e4ckhed F (2017) Role of gut microbiota in atherosclerosis. Nat Rev Cardiol 14(2):79\u201387","journal-title":"Nat Rev Cardiol"},{"issue":"12","key":"13007_CR92","doi-asserted-by":"crossref","first-page":"786","DOI":"10.7326\/M20-0336","volume":"172","author":"SP Juraschek","year":"2020","unstructured":"Juraschek SP, Kovell LC, Appel LJ, Miller ER III, Sacks FM, Christenson RH, Rebuck H, Chang AR, Mukamal KJ (2020) Associations between dietary patterns and subclinical cardiac injury: an observational analysis from the DASH trial. Ann Intern Med 172(12):786\u2013794","journal-title":"Ann Intern Med"},{"issue":"17","key":"13007_CR93","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1161\/circulationaha.119.043081","volume":"141","author":"DM Kaye","year":"2020","unstructured":"Kaye DM, Shihata WA, Jama HA, Tsyganov K, Ziemann M, Kiriazis H, Horlock D, Vijay A, Giam B, Vinh A, Johnson C, Fiedler A, Donner D, Snelson M, Coughlan MT, Phillips S, Du XJ, El-Osta A, Drummond G, Lambert GW, Spector TD, Valdes AM, Mackay CR, Marques FZ (2020) Deficiency of prebiotic fiber and insufficient signaling through gut metabolite-sensing receptors leads to cardiovascular disease. Circulation 141(17):1393\u20131403. https:\/\/doi.org\/10.1161\/circulationaha.119.043081","journal-title":"Circulation"},{"issue":"1","key":"13007_CR94","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40168-020-00821-0","volume":"8","author":"N Kazemian","year":"2020","unstructured":"Kazemian N, Mahmoudi M, Halperin F, Wu JC, Pakpour S (2020) Gut microbiota and cardiovascular disease: opportunities and challenges. Microbiome 8(1):1\u201317","journal-title":"Microbiome"},{"issue":"3","key":"13007_CR95","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1002\/jpen.2193","volume":"46","author":"SK Kirschner","year":"2022","unstructured":"Kirschner SK, Deutz NEP, Rijnaarts I, Smit TJ, Larsen DJ, Engelen MPKJ (2022) Impaired intestinal function is associated with lower muscle and cognitive health and well-being in patients with congestive heart failure. Jpen-Parenter Enter 46(3):660\u2013670. https:\/\/doi.org\/10.1002\/jpen.2193","journal-title":"Jpen-Parenter Enter"},{"issue":"5","key":"13007_CR96","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1038\/nm.3145","volume":"19","author":"RA Koeth","year":"2013","unstructured":"Koeth RA, Wang Z, Levison BS, Buffa JA, Org E, Sheehy BT, Britt EB, Fu X, Wu Y, Li L (2013) Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis. Nat Med 19(5):576\u2013585","journal-title":"Nat Med"},{"issue":"4","key":"13007_CR97","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/j.molcel.2020.03.005","volume":"78","author":"A Koh","year":"2020","unstructured":"Koh A, Backhed F (2020) From association to causality: the role of the gut microbiota and its functional products on host metabolism. Mol Cell 78(4):584\u2013596. https:\/\/doi.org\/10.1016\/j.molcel.2020.03.005","journal-title":"Mol Cell"},{"issue":"10","key":"13007_CR98","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1016\/j.jacc.2017.12.057","volume":"71","author":"M Kummen","year":"2018","unstructured":"Kummen M, Mayerhofer CC, Vestad B, Broch K, Awoyemi A, Storm-Larsen C, Ueland T, Yndestad A, Hov JR, Tr\u00f8seid M (2018) Gut microbiota signature in heart failure defined from profiling of 2 independent cohorts. J Am Coll Cardiol 71(10):1184\u20131186","journal-title":"J Am Coll Cardiol"},{"issue":"18","key":"13007_CR99","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1016\/j.jacc.2022.08.771","volume":"80","author":"I L\u00e1zaro","year":"2022","unstructured":"L\u00e1zaro I, Lup\u00f3n J, Cediel G, Codina P, Fit\u00f3 M, Domingo M, Santiago-Vacas E, Zamora E, Sala-Vila A, Bay\u00e9s-Gen\u00eds A (2022) Relationship of circulating vegetable omega-3 to prognosis in patients with heart failure. J Am Coll Cardiol 80(18):1751\u20131758","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"13007_CR100","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/dom.13561","volume":"21","author":"P Lee","year":"2019","unstructured":"Lee P, Yacyshyn BR, Yacyshyn MB (2019) Gut microbiota and obesity: an opportunity to alter obesity through faecal microbiota transplant (FMT). Diabetes Obes Metab 21(3):479\u2013490","journal-title":"Diabetes Obes Metab"},{"key":"13007_CR101","doi-asserted-by":"crossref","first-page":"5205126","DOI":"10.1155\/2018\/5205126","volume":"2018","author":"AM Leustean","year":"2018","unstructured":"Leustean AM, Ciocoiu M, Sava A, Costea CF, Floria M, Tarniceriu CC, Tanase DM (2018) Implications of the intestinal microbiota in diagnosing the progression of diabetes and the presence of cardiovascular complications. J Diabetes Res 2018:5205126","journal-title":"J Diabetes Res"},{"issue":"6","key":"13007_CR102","doi-asserted-by":"publisher","first-page":"H1227","DOI":"10.1152\/ajpheart.00612.2020","volume":"319","author":"CV Lewis","year":"2020","unstructured":"Lewis CV, Taylor WR (2020) Intestinal barrier dysfunction as a therapeutic target for cardiovascular disease. Am J Physiol-Heart C 319(6):H1227\u2013H1233. https:\/\/doi.org\/10.1152\/ajpheart.00612.2020","journal-title":"Am J Physiol-Heart C"},{"key":"13007_CR103","doi-asserted-by":"crossref","first-page":"104663","DOI":"10.1016\/j.phrs.2020.104663","volume":"153","author":"AM Lewis-Mikhael","year":"2020","unstructured":"Lewis-Mikhael AM, Davoodvandi A, Jafarnejad S (2020) Effect of Lactobacillusplantarum containing probiotics on blood pressure: a systematic review and meta-analysis. Pharmacol Res 153:104663","journal-title":"Pharmacol Res"},{"issue":"5","key":"13007_CR104","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/j.bbadis.2018.05.011","volume":"1865","author":"J Li","year":"2019","unstructured":"Li J, Dawson PA (2019) Animal models to study bile acid metabolism. Bba-Mol Basis Dis 1865(5):895\u2013911. https:\/\/doi.org\/10.1016\/j.bbadis.2018.05.011","journal-title":"Bba-Mol Basis Dis"},{"issue":"3","key":"13007_CR105","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/s41374-018-0091-y","volume":"99","author":"Z Li","year":"2019","unstructured":"Li Z, Wu Z, Yan J, Liu H, Liu Q, Deng Y, Ou C, Chen M (2019) Gut microbe-derived metabolite trimethylamine N-oxide induces cardiac hypertrophy and fibrosis. Lab Invest 99(3):346\u2013357","journal-title":"Lab Invest"},{"key":"13007_CR106","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.3389\/fphar.2020.01247","volume":"11","author":"C Li","year":"2020","unstructured":"Li C, Yang J, Wang Y, Qi Y, Yang W, Li Y (2020a) Farnesoid X receptor agonists as therapeutic target for cardiometabolic diseases. Front Pharmacol 11:1247","journal-title":"Front Pharmacol"},{"issue":"1","key":"13007_CR107","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1093\/ajcn\/nqac074","volume":"116","author":"DD Li","year":"2022","unstructured":"Li DD, Lu Y, Yuan S, Cai XX, He Y, Chen J, Wu Q, He D, Fang AP, Bo YC, Song PG, Bogaert D, Tsilidis K, Larsson SC, Yu HL, Zhu HL, Theodoratou E, Zhu YM, Li X (2022a) Gut microbiota-derived metabolite trimethylamine-N-oxide and multiple health outcomes: an umbrella review and updated meta-analysis. Am J Clin Nutr 116(1):230\u2013243. https:\/\/doi.org\/10.1093\/ajcn\/nqac074","journal-title":"Am J Clin Nutr"},{"key":"13007_CR108","doi-asserted-by":"publisher","first-page":"3893","DOI":"10.2147\/ijn.S370784","volume":"17","author":"DF Li","year":"2022","unstructured":"Li DF, Yang MF, Xu J, Xu HM, Zhu MZ, Liang YJ, Zhang Y, Tian CM, Nie YQ, Shi RY, Wang LS, Yao J (2022b) Extracellular vesicles: the next generation theranostic nanomedicine for inflammatory bowel disease. Int J Nanomed 17:3893\u20133911. https:\/\/doi.org\/10.2147\/ijn.S370784","journal-title":"Int J Nanomed"},{"issue":"10","key":"13007_CR109","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.1093\/jn\/nxac103","volume":"152","author":"Q Li","year":"2022","unstructured":"Li Q, Zhang X, Du YS, Liu XP, Chen GY, Xiang PY, Wu H, Liu CQ, Wang DL (2022c) Brussels chicory stabilizes unstable atherosclerotic plaques and reshapes the gut microbiota in Apoe(-\/-) mice. J Nutr 152(10):2209\u20132217. https:\/\/doi.org\/10.1093\/jn\/nxac103","journal-title":"J Nutr"},{"key":"13007_CR110","doi-asserted-by":"publisher","unstructured":"Li W, Chen C, Chen M, Zhang X, Ji Q, Wang Y, Zheng Q, Tan S, Gao X, Lu Y (2020b) Salted and unsalted Zhacai (Brassica juncea var. tumida) alleviated high-fat diet-induced dyslipidemia by regulating gut microbiota: a multiomics study. Mol Nutr Food Res 64(24) https:\/\/doi.org\/10.1002\/mnfr.202000798","DOI":"10.1002\/mnfr.202000798"},{"key":"13007_CR111","doi-asserted-by":"publisher","unstructured":"Li SY, Chen S, Lu XT, Fang AP, Chen YM, Huang RZ, Lin XL, Huang ZH, Ma JF, Huang BX, Zhu HL (2022d) Serum trimethylamine-N-oxide is associated with incident type 2 diabetes in middle-aged and older adults: a prospective cohort study. 74 20(1) https:\/\/doi.org\/10.1186\/s12967-022-03581-7","DOI":"10.1186\/s12967-022-03581-7"},{"key":"13007_CR112","doi-asserted-by":"crossref","first-page":"110941","DOI":"10.1016\/j.nut.2020.110941","volume":"79","author":"X Liang","year":"2020","unstructured":"Liang X, Zhang Z, Lv Y, Tong L, Liu T, Yi H, Zhou X, Yu Z, Tian X, Cui Q (2020) Reduction of intestinal trimethylamine by probiotics ameliorated lipid metabolic disorders associated with atherosclerosis. Nutrition 79:110941","journal-title":"Nutrition"},{"issue":"10","key":"13007_CR113","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1080\/10408398.2020.1764488","volume":"61","author":"T Liang","year":"2020","unstructured":"Liang T, Wu L, Xi Y, Li Y, Xie X, Fan C, Yang L, Yang S, Chen X, Zhang J (2020) Probiotics supplementation improves hyperglycemia, hypercholesterolemia, and hypertension in type 2 diabetes mellitus: an update of meta-analysis. Crit Rev Food Sci 61(10):1670\u20131688","journal-title":"Crit Rev Food Sci"},{"key":"13007_CR114","doi-asserted-by":"crossref","first-page":"106270","DOI":"10.1016\/j.cct.2021.106270","volume":"102","author":"X Liu","year":"2021","unstructured":"Liu X, Morris MC, Dhana K, Ventrelle J, Johnson K, Bishop L, Hollings CS, Boulin A, Laranjo N, Stubbs BJ (2021a) Mediterranean-DASH Intervention for Neurodegenerative Delay (MIND) study: rationale, design and baseline characteristics of a randomized control trial of the MIND diet on cognitive decline. Contemp Clin Trials 102:106270","journal-title":"Contemp Clin Trials"},{"key":"13007_CR115","doi-asserted-by":"crossref","first-page":"e1277","DOI":"10.6061\/clinics\/2020\/e1277","volume":"75","author":"Y Liu","year":"2020","unstructured":"Liu Y, Lou X (2020) Type 2 diabetes mellitus-related environmental factors and the gut microbiota: emerging evidence and challenges. Clinics (Sao Paulo) 75:e1277","journal-title":"Clinics (Sao Paulo)"},{"key":"13007_CR116","doi-asserted-by":"publisher","unstructured":"Liu Y, Jiang Q, Liu Z, Shen S, Ai J, Zhu Y, Zhou L (2021b) Alteration of gut microbiota relates to metabolic disorders in primary aldosteronism patients. Front Endocrinol 12 https:\/\/doi.org\/10.3389\/fendo.2021.667951","DOI":"10.3389\/fendo.2021.667951"},{"key":"13007_CR117","first-page":"1647","volume":"368","author":"J Loscalzo","year":"2013","unstructured":"Loscalzo J (2013) Gut microbiota, the genome, and diet in atherogenesis. Mass Medical Soc 368:1647\u20131649","journal-title":"Mass Medical Soc"},{"key":"13007_CR118","doi-asserted-by":"publisher","unstructured":"Lu Y, Zhang Y, Zhao X, Shang C, Xiang M, Li L, Cui X (2022) Microbiota-derived short-chain fatty acids: implications for cardiovascular and metabolic disease. Front Cardiovasc Med 9 https:\/\/doi.org\/10.3389\/fcvm.2022.900381","DOI":"10.3389\/fcvm.2022.900381"},{"issue":"3","key":"13007_CR119","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1002\/ehf2.12155","volume":"4","author":"M Luedde","year":"2017","unstructured":"Luedde M, Winkler T, Heinsen FA, R\u00fchlemann MC, Spehlmann ME, Bajrovic A, Lieb W, Franke A, Ott SJ, Frey N (2017) Heart failure is associated with depletion of core intestinal microbiota. ESC Heart Failure 4(3):282\u2013290","journal-title":"ESC Heart Failure"},{"key":"13007_CR120","doi-asserted-by":"publisher","first-page":"899746","DOI":"10.3389\/fnut.2022.899746","volume":"9","author":"Q Luo","year":"2022","unstructured":"Luo Q, Hu Y, Chen X, Luo Y, Chen J, Wang H (2022) Effects of gut microbiota and metabolites on heart failure and its risk factors: a two-sample Mendelian randomization study. Front Nutr 9:899746. https:\/\/doi.org\/10.3389\/fnut.2022.899746","journal-title":"Front Nutr"},{"key":"13007_CR121","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.3389\/fphar.2018.01082","volume":"9","author":"J Ma","year":"2018","unstructured":"Ma J, Li H (2018) The role of gut microbiota in atherosclerosis and hypertension. Front Pharmacol 9:1082","journal-title":"Front Pharmacol"},{"issue":"8","key":"13007_CR122","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/j.tibtech.2018.02.014","volume":"36","author":"M Mahmoudi","year":"2018","unstructured":"Mahmoudi M (2018) Debugging nano-bio interfaces: systematic strategies to accelerate clinical translation of nanotechnologies. Trends Biotechnol 36(8):755\u2013769. https:\/\/doi.org\/10.1016\/j.tibtech.2018.02.014","journal-title":"Trends Biotechnol"},{"issue":"23","key":"13007_CR123","doi-asserted-by":"crossref","first-page":"4050","DOI":"10.2174\/0929867328666211213112949","volume":"29","author":"AA Manolis","year":"2022","unstructured":"Manolis AA, Manolis TA, Melita H, Manolis AS (2022) Gut microbiota and cardiovascular disease: symbiosis versus dysbiosis. Curr Med Chem 29(23):4050\u20134077","journal-title":"Curr Med Chem"},{"key":"13007_CR124","doi-asserted-by":"publisher","unstructured":"Margina D, Ungurianu A, Purdel C, Nitulescu GM, Tsoukalas D, Sarandi E, Thanasoula M, Burykina TI, Tekos F, Buha A, Nikitovic D, Kouretas D, Tsatsakis AM (2020) Analysis of the intricate effects of polyunsaturated fatty acids and polyphenols on inflammatory pathways in health and disease. Food Chem Toxicol 143 https:\/\/doi.org\/10.1016\/j.fct.2020.111558","DOI":"10.1016\/j.fct.2020.111558"},{"key":"13007_CR125","doi-asserted-by":"crossref","first-page":"428","DOI":"10.3389\/fphys.2019.00428","volume":"10","author":"AM Martin","year":"2019","unstructured":"Martin AM, Sun EW, Rogers GB, Keating DJ (2019) The influence of the gut microbiome on host metabolism through the regulation of gut hormone release. Front Physiol 10:428","journal-title":"Front Physiol"},{"issue":"5","key":"13007_CR126","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1161\/CIRCRESAHA.118.313348","volume":"124","author":"MA Mart\u00ednez-Gonz\u00e1lez","year":"2019","unstructured":"Mart\u00ednez-Gonz\u00e1lez MA, Gea A, Ruiz-Canela M (2019) The Mediterranean diet and cardiovascular health: a critical review. Circ Res 124(5):779\u2013798","journal-title":"Circ Res"},{"issue":"9","key":"13007_CR127","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1016\/j.cardfail.2017.06.007","volume":"23","author":"CCK Mayerhofer","year":"2017","unstructured":"Mayerhofer CCK, Ueland T, Broch K, Vincent RP, Cross GF, Dahl CP, Aukrust P, Gullestad L, Hov JR, Troseid M (2017) Increased secondary\/primary bile acid ratio in chronic heart failure. J Card Fail 23(9):666\u2013671. https:\/\/doi.org\/10.1016\/j.cardfail.2017.06.007","journal-title":"J Card Fail"},{"issue":"6","key":"13007_CR128","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1093\/ajcn\/nqab001","volume":"113","author":"Z Mei","year":"2021","unstructured":"Mei Z, Chen G-C, Wang Z, Usyk M, Yu B, Baeza YV, Humphrey G, Benitez RS, Li J, Williams-Nguyen JS (2021) Dietary factors, gut microbiota, and serum trimethylamine-N-oxide associated with cardiovascular disease in the Hispanic Community Health Study\/Study of Latinos. Am J Clin Nutr 113(6):1503\u20131514","journal-title":"Am J Clin Nutr"},{"key":"13007_CR129","doi-asserted-by":"crossref","unstructured":"Millet YA, Meisner J, Tan J, Jose A, Humphries E, Miller KJ, Bayne C, McComb M, Giuggio M, Konopnicki CM (2022) Modulation of the gut microbiome by novel synthetic glycans for the production of propionate and the reduction of cardiometabolic risk factors. bioRxiv 2022\u201304","DOI":"10.1101\/2022.04.04.487010"},{"issue":"4","key":"13007_CR130","first-page":"1","volume":"41","author":"L Min","year":"2018","unstructured":"Min L, Qinghua H, Jinglu Y (2018) Trimethylamine-N-oxide (TMAO) increased aquaporin-2 expression in spontaneously hypertensive rats. Clin Exp Hypertens 41(4):1\u201311","journal-title":"Clin Exp Hypertens"},{"key":"13007_CR131","doi-asserted-by":"crossref","unstructured":"Molinero N, Ruiz L, S\u00e1nchez B, Margolles A, Delgado S (2019) Intestinal bacteria interplay with bile and cholesterol metabolism: implications on host physiology. Front Physiol 185","DOI":"10.3389\/fphys.2019.00185"},{"issue":"8","key":"13007_CR132","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.arcmed.2017.11.003","volume":"48","author":"S Moran-Ramos","year":"2017","unstructured":"Moran-Ramos S, L\u00f3pez-Contreras BE, Canizales-Quinteros S (2017) Gut microbiota in obesity and metabolic abnormalities: a matter of composition or functionality? Arch Med Res 48(8):735\u2013753","journal-title":"Arch Med Res"},{"issue":"9","key":"13007_CR133","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1016\/s0002-9149(97)89206-5","volume":"77","author":"MA Munger","year":"1996","unstructured":"Munger MA, Johnson B, Amber IJ, Callahan KS, Gilbert EM (1996) Circulating concentrations of proinflammatory cytokines in mild or moderate heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 77(9):723\u2013727. https:\/\/doi.org\/10.1016\/s0002-9149(97)89206-5","journal-title":"Am J Cardiol"},{"issue":"5","key":"13007_CR134","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.cell.2020.02.016","volume":"180","author":"I Nemet","year":"2020","unstructured":"Nemet I, Saha PP, Gupta N, Zhu W, Romano KA, Skye SM, Cajka T, Mohan ML, Li L, Wu Y (2020) A cardiovascular disease-linked gut microbial metabolite acts via adrenergic receptors. Cell 180(5):862\u2013877","journal-title":"Cell"},{"issue":"4","key":"13007_CR135","doi-asserted-by":"crossref","first-page":"1900797","DOI":"10.1002\/mnfr.201900797","volume":"64","author":"VL O'Morain","year":"2020","unstructured":"O\u2019Morain VL, Ramji DP (2020) The potential of probiotics in the prevention and treatment of atherosclerosis. Mol Nutr Food Res 64(4):1900797","journal-title":"Mol Nutr Food Res"},{"issue":"1","key":"13007_CR136","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jand.2021.08.112","volume":"122","author":"I Opoku-Acheampong","year":"2022","unstructured":"Opoku-Acheampong I, McLaud T, Anderson OS (2022) Fecal microbiota transplantation to prevent and treat chronic disease: implications for dietetics practice. J Acad Nutr Diet 122(1):33\u201337","journal-title":"J Acad Nutr Diet"},{"issue":"3","key":"13007_CR137","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1210\/clinem\/dgab773","volume":"107","author":"FJ Osuna-Prieto","year":"2022","unstructured":"Osuna-Prieto FJ, Rubio-Lopez J, Di X, Yang W, Kohler I, Rensen PC, Ruiz JR, Martinez-Tellez B (2022) Plasma levels of bile acids are related to cardiometabolic risk factors in young adults. J Clin Endocrinology Metabolism 107(3):715\u2013723","journal-title":"J Clin Endocrinology Metabolism"},{"issue":"2","key":"13007_CR138","doi-asserted-by":"publisher","first-page":"H475","DOI":"10.1152\/ajpheart.00573.2020","volume":"320","author":"N Pakhomov","year":"2021","unstructured":"Pakhomov N, Baugh JA (2021) The role of diet-derived short-chain fatty acids in regulating cardiac pressure overload. Am J Physiol-Heart C 320(2):H475\u2013H486. https:\/\/doi.org\/10.1152\/ajpheart.00573.2020","journal-title":"Am J Physiol-Heart C"},{"issue":"15","key":"13007_CR139","doi-asserted-by":"crossref","first-page":"e016641","DOI":"10.1161\/JAHA.120.016641","volume":"9","author":"J Palmu","year":"2020","unstructured":"Palmu J, Salosensaari A, Havulinna AS, Cheng S, Inouye M, Jain M, Salido RA, Sanders K, Brennan C, Humphrey GC (2020) Association between the gut microbiota and blood pressure in a population cohort of 6953 individuals. J Am Heart Assoc 9(15):e016641","journal-title":"J Am Heart Assoc"},{"issue":"6","key":"13007_CR140","doi-asserted-by":"crossref","first-page":"e005784","DOI":"10.1161\/JAHA.117.005784","volume":"6","author":"D Pastori","year":"2017","unstructured":"Pastori D, Carnevale R, Nocella C, Novo M, Santulli M, Cammisotto V, Menichelli D, Pignatelli P, Violi F (2017) Gut-derived serum lipopolysaccharide is associated with enhanced risk of major adverse cardiovascular events in atrial fibrillation: Effect of adherence to mediterranean diet. J Am Heart Assoc 6(6):e005784","journal-title":"J Am Heart Assoc"},{"issue":"7612","key":"13007_CR141","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1038\/nature18646","volume":"535","author":"HK Pedersen","year":"2016","unstructured":"Pedersen HK, Gudmundsdottir V, Nielsen HB, Hyotylainen T, Nielsen T, Jensen BAH, Forslund K, Hildebrand F, Prifti E, Falony G, Le Chatelier E, Levenez F, Dore J, Mattila I, Plichta DR, Poho P, Hellgren LI, Arumugam M, Sunagawa S, Vieira-Silva S, Jorgensen T, Holm JB, Trost K, Kristiansen K, Brix S, Raes J, Wang J, Hansen T, Bork P, Brunak S, Oresic M, Ehrlich SD, Pedersen O, Meta HITC (2016) Human gut microbes impact host serum metabolome and insulin sensitivity. Nature 535(7612):376. https:\/\/doi.org\/10.1038\/nature18646","journal-title":"Nature"},{"issue":"22","key":"13007_CR142","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1001\/jama.2018.6741","volume":"319","author":"DM Qato","year":"2018","unstructured":"Qato DM, Ozenberger K, Olfson M (2018) Prevalence of prescription medications with depression as a potential adverse effect among adults in the United States. JAMA 319(22):2289\u20132298","journal-title":"JAMA"},{"issue":"1","key":"13007_CR143","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12944-019-1182-5","volume":"19","author":"D Qi","year":"2020","unstructured":"Qi D, Nie X-L, Zhang J-J (2020) The effect of probiotics supplementation on blood pressure: a systemic review and meta-analysis. Lipids Health Dis 19(1):1\u201311","journal-title":"Lipids Health Dis"},{"issue":"4","key":"13007_CR144","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1097\/fjc.0000000000001320","volume":"80","author":"S Qi","year":"2022","unstructured":"Qi S, Luo X, Liu S, Ling B, Jin H (2022) The critical effect of bile acids in atherosclerosis. J Cardiovasc Pharm 80(4):562\u2013573. https:\/\/doi.org\/10.1097\/fjc.0000000000001320","journal-title":"J Cardiovasc Pharm"},{"key":"13007_CR145","doi-asserted-by":"crossref","unstructured":"Quek J, Lim G, Lim WH, Ng CH, So WZ, Toh J, Pan XH, Chin YH, Muthiah MD, Chan SP (2021) The association of plant-based diet with cardiovascular disease and mortality: a meta-analysis and systematic review of prospect cohort studies. Front Cardiovasc Med 8","DOI":"10.3389\/fcvm.2021.756810"},{"issue":"25","key":"13007_CR146","doi-asserted-by":"crossref","first-page":"3060","DOI":"10.1161\/01.CIR.102.25.3060","volume":"102","author":"M Rauchhaus","year":"2000","unstructured":"Rauchhaus M, Doehner W, Francis DP, Davos C, Kemp M, Liebenthal C, Niebauer J, Hooper J, Volk HD, Coats AJS, Anker SD (2000) Plasma cytokine parameters and mortality in patients with chronic heart failure. Circulation 102(25):3060\u20133067","journal-title":"Circulation"},{"key":"13007_CR147","doi-asserted-by":"crossref","unstructured":"Rees K, Takeda A, Martin N, Ellis L, Wijesekara D, Vepa A, Das A, Hartley L, Stranges S (2019) Mediterranean\u2010style diet for the primary and secondary prevention of cardiovascular disease. Cochrane Db Syst Rev (3)","DOI":"10.1002\/14651858.CD009825.pub3"},{"issue":"6150","key":"13007_CR148","doi-asserted-by":"crossref","first-page":"1241214","DOI":"10.1126\/science.1241214","volume":"341","author":"VK Ridaura","year":"2013","unstructured":"Ridaura VK, Faith JJ, Rey FE, Cheng J, Duncan AE, Kau AL, Griffin NW, Lombard V, Henrissat B, Bain JR (2013) Gut microbiota from twins discordant for obesity modulate metabolism in mice. Science 341(6150):1241214","journal-title":"Science"},{"issue":"9","key":"13007_CR149","doi-asserted-by":"publisher","first-page":"2006","DOI":"10.1111\/bph.14965","volume":"177","author":"I Robles-Vera","year":"2020","unstructured":"Robles-Vera I, Toral M, de la Visitacion N, Sanchez M, Gomez-Guzman M, Munoz R, Algieri F, Vezza T, Jimenez R, Galvez J, Romero M, Miguel Redondo J, Duarte J (2020) Changes to the gut microbiota induced by losartan contributes to its antihypertensive effects. Brit J Pharmacol 177(9):2006\u20132023. https:\/\/doi.org\/10.1111\/bph.14965","journal-title":"Brit J Pharmacol"},{"issue":"25","key":"13007_CR150","doi-asserted-by":"crossref","first-page":"2982","DOI":"10.1016\/j.jacc.2020.11.010","volume":"76","author":"GA Roth","year":"2020","unstructured":"Roth GA, Mensah GA, Johnson CO, Addolorato G, Ammirati E, Baddour LM, Barengo NC, Beaton AZ, Benjamin EJ, Benziger CP (2020) Global burden of cardiovascular diseases and risk factors, 1990\u20132019: update from the GBD 2019 study. J Am Coll Cardiol 76(25):2982\u20133021","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"13007_CR151","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.pcad.2018.04.006","volume":"61","author":"J Salas-Salvad\u00f3","year":"2018","unstructured":"Salas-Salvad\u00f3 J, Becerra-Tom\u00e1s N, Garc\u00eda-Gavil\u00e1n JF, Bullo M, Barrubes L (2018) Mediterranean diet and cardiovascular disease prevention: what do we know? Prog Cardiovasc Dis 61(1):62\u201367","journal-title":"Prog Cardiovasc Dis"},{"issue":"5","key":"13007_CR152","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11906-020-01046-0","volume":"22","author":"Y Sata","year":"2020","unstructured":"Sata Y, Marques FZ, Kaye DM (2020) The emerging role of gut dysbiosis in cardio-metabolic risk factors for heart failure. Curr Hypertens Rep 22(5):1\u20138","journal-title":"Curr Hypertens Rep"},{"key":"13007_CR153","doi-asserted-by":"crossref","first-page":"103176","DOI":"10.1016\/j.ebiom.2020.103176","volume":"63","author":"H Schellekens","year":"2021","unstructured":"Schellekens H, Torres-Fuentes C, van de Wouw M, Long-Smith CM, Mitchell A, Strain C, Berding K, Bastiaanssen TF, Rea K, Golubeva AV (2021) Bifidobacterium longum counters the effects of obesity: partial successful translation from rodent to human. EBioMedicine 63:103176","journal-title":"EBioMedicine"},{"key":"13007_CR154","doi-asserted-by":"crossref","unstructured":"Shah RV, Steffen LM, Nayor M, Reis JP, Jacobs DR, Allen NB, Lloyd-Jones D, Meyer K, Cole J, Piaggi P (2022) Dietary metabolic signatures and cardiometabolic risk. Eur Heart J","DOI":"10.1093\/eurheartj\/ehac446"},{"issue":"2","key":"13007_CR155","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.chom.2019.01.017","volume":"25","author":"AN Shkoporov","year":"2019","unstructured":"Shkoporov AN, Hill C (2019) Bacteriophages of the human gut: the \u201cknown unknown\u201d of the microbiome. Cell Host Microbe 25(2):195\u2013209","journal-title":"Cell Host Microbe"},{"issue":"7","key":"13007_CR156","doi-asserted-by":"crossref","first-page":"e008342","DOI":"10.1161\/JAHA.117.008342","volume":"7","author":"LP Smits","year":"2018","unstructured":"Smits LP, Kootte RS, Levin E, Prodan A, Fuentes S, Zoetendal EG, Wang Z, Levison BS, Cleophas MC, Kemper EM (2018) Effect of vegan fecal microbiota transplantation on carnitine-and choline-derived trimethylamine-N-oxide production and vascular inflammation in patients with metabolic syndrome. J Am Heart Assoc 7(7):e008342","journal-title":"J Am Heart Assoc"},{"issue":"5","key":"13007_CR157","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/s13238-018-0546-3","volume":"9","author":"LJ Sun","year":"2018","unstructured":"Sun LJ, Ma LJ, Ma YB, Zhang FM, Zhao CH, Nie YZ (2018) Insights into the role of gut microbiota in obesity: pathogenesis, mechanisms, and therapeutic perspectives. Protein Cell 9(5):397\u2013403. https:\/\/doi.org\/10.1007\/s13238-018-0546-3","journal-title":"Protein Cell"},{"issue":"5","key":"13007_CR158","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1161\/HYPERTENSIONAHA.118.12109","volume":"73","author":"S Sun","year":"2019","unstructured":"Sun S, Lulla A, Sioda M, Winglee K, Wu MC, Jacobs DR Jr, Shikany JM, Lloyd-Jones DM, Launer LJ, Fodor AA (2019) Gut microbiota composition and blood pressure: the CARDIA study. Hypertension 73(5):998\u20131006","journal-title":"Hypertension"},{"issue":"7","key":"13007_CR159","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1002\/ejhf.1338","volume":"21","author":"T Suzuki","year":"2019","unstructured":"Suzuki T, Yazaki Y, Voors AA, Jones DJ, Chan DC, Anker SD, Cleland JG, Dickstein K, Filippatos G, Hillege HL (2019) Association with outcomes and response to treatment of trimethylamine N-oxide in heart failure: results from BIOSTAT-CHF. Eur J Heart Fail 21(7):877\u2013886","journal-title":"Eur J Heart Fail"},{"issue":"13","key":"13007_CR160","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.3390\/nu14132649","volume":"14","author":"E Szczepa\u0144ska","year":"2022","unstructured":"Szczepa\u0144ska E, Bia\u0142ek-Dratwa A, Janota B, Kowalski O (2022) Dietary therapy in prevention of cardiovascular disease (CVD)\u2014tradition or modernity? A review of the latest approaches to nutrition in CVD. Nutrients 14(13):2649","journal-title":"Nutrients"},{"issue":"3","key":"13007_CR161","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/s41569-018-0108-7","volume":"16","author":"W Tang","year":"2019","unstructured":"Tang W, Li DY, Hazen SL (2019a) Dietary metabolism, the gut microbiome, and heart failure. Nat Rev Cardiol 16(3):137\u2013154","journal-title":"Nat Rev Cardiol"},{"issue":"16","key":"13007_CR162","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1016\/j.jacc.2019.03.024","volume":"73","author":"WW Tang","year":"2019","unstructured":"Tang WW, B\u00e4ckhed F, Landmesser U, Hazen SL (2019b) Intestinal microbiota in cardiovascular health and disease: JACC state-of-the-art review. J Am Coll Cardiol 73(16):2089\u20132105","journal-title":"J Am Coll Cardiol"},{"key":"13007_CR163","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.ahj.2021.01.020","volume":"236","author":"WHW Tang","year":"2021","unstructured":"Tang WHW, Li XS, Wu YP, Wang ZN, Khaw KT, Wareham NJ, Nieuwdorp M, Boekholdt SM, Hazen SL (2021) Plasma trimethylamine N-oxide (TMAO) levels predict future risk of coronary artery disease in apparently healthy individuals in the EPIC-Norfolk prospective population study. Am Heart J 236:80\u201386. https:\/\/doi.org\/10.1016\/j.ahj.2021.01.020","journal-title":"Am Heart J"},{"key":"13007_CR164","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.cca.2022.09.018","volume":"536","author":"Y Tang","year":"2022","unstructured":"Tang Y, Zou Y, Cui J, Ma X, Zhang L, Yu S, Qiu L (2022) Analysis of two intestinal bacterial metabolites (trimethylamine N-oxide and phenylacetylglutamine) in human serum samples of patients with T2DM and AMI using a liquid chromatography tandem mass spectrometry method. Clin Chim Acta 536:162\u2013168","journal-title":"Clin Chim Acta"},{"issue":"5","key":"13007_CR165","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.3390\/nu13051697","volume":"13","author":"L Testai","year":"2021","unstructured":"Testai L, Martelli A, Flori L, Cicero AF, Colletti A (2021) Coenzyme Q10: clinical applications beyond cardiovascular diseases. Nutrients 13(5):1697","journal-title":"Nutrients"},{"issue":"2","key":"13007_CR166","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.chom.2019.07.004","volume":"26","author":"LB Thingholm","year":"2019","unstructured":"Thingholm LB, R\u00fchlemann MC, Koch M, Fuqua B, Laucke G, Boehm R, Bang C, Franzosa EA, H\u00fcbenthal M, Rahnavard A (2019) Obese individuals with and without type 2 diabetes show different gut microbial functional capacity and composition. Cell Host Microbe 26(2):252-264.e10","journal-title":"Cell Host Microbe"},{"issue":"10","key":"13007_CR167","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/S2468-1253(17)30147-4","volume":"2","author":"C Torres-Fuentes","year":"2017","unstructured":"Torres-Fuentes C, Schellekens H, Dinan TG, Cryan JF (2017) The microbiota\u2013gut\u2013brain axis in obesity. Lancet Gastroenterol Hepatol 2(10):747\u2013756","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"9","key":"13007_CR168","doi-asserted-by":"crossref","first-page":"2671","DOI":"10.3390\/nu12092671","volume":"12","author":"EA Trautwein","year":"2020","unstructured":"Trautwein EA, McKay S (2020) The role of specific components of a plant-based diet in management of dyslipidemia and the impact on cardiovascular risk. Nutrients 12(9):2671","journal-title":"Nutrients"},{"issue":"8","key":"13007_CR169","first-page":"e153","volume":"145","author":"CW Tsao","year":"2022","unstructured":"Tsao CW, Aday AW, Almarzooq ZI, Alonso A, Beaton AZ, Bittencourt MS, Boehme AK, Buxton AE, Carson AP, Commodore-Mensah Y (2022) Heart disease and stroke statistics\u20142022 update: a report from the American Heart Association. Circulation 145(8):e153\u2013e639","journal-title":"Circulation"},{"issue":"7792","key":"13007_CR170","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1038\/d41586-020-00202-5","volume":"577","author":"PJ Turnbaugh","year":"2020","unstructured":"Turnbaugh PJ (2020) Diet should be a tool for researchers, not a treatment. Nature 577(7792):S23\u2013S23","journal-title":"Nature"},{"issue":"44","key":"13007_CR171","doi-asserted-by":"crossref","first-page":"4259","DOI":"10.1093\/eurheartj\/ehaa704","volume":"41","author":"BJ Verhaar","year":"2020","unstructured":"Verhaar BJ, Collard D, Prodan A, Levels JH, Zwinderman AH, B\u00e4ckhed F, Vogt L, Peters MJ, Muller M, Nieuwdorp M (2020) Associations between gut microbiota, faecal short-chain fatty acids, and blood pressure across ethnic groups: the HELIUS study. Eur Heart J 41(44):4259\u20134267","journal-title":"Eur Heart J"},{"issue":"2","key":"13007_CR172","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.cell.2019.12.025","volume":"180","author":"J Walter","year":"2020","unstructured":"Walter J, Armet AM, Finlay BB, Shanahan F (2020) Establishing or exaggerating causality for the gut microbiome: lessons from human microbiota-associated rodents. Cell 180(2):221\u2013232","journal-title":"Cell"},{"issue":"5","key":"13007_CR173","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1681\/ASN.2014121271","volume":"27","author":"XX Wang","year":"2016","unstructured":"Wang XX, Edelstein MH, Gafter U, Qiu L, Luo Y, Dobrinskikh E, Lucia S, Adorini L, D\u2019Agati VD, Levi J (2016) G protein-coupled bile acid receptor TGR5 activation inhibits kidney disease in obesity and diabetes. J Am Soc Nephrol 27(5):1362\u20131378","journal-title":"J Am Soc Nephrol"},{"issue":"11","key":"13007_CR174","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1080\/13543776.2018.1527906","volume":"28","author":"H Wang","year":"2018","unstructured":"Wang H, He Q, Wang G, Xu X, Hao H (2018a) FXR modulators for enterohepatic and metabolic diseases. Expert Opin Ther Pat 28(11):765\u2013782","journal-title":"Expert Opin Ther Pat"},{"issue":"9","key":"13007_CR175","doi-asserted-by":"crossref","first-page":"8943","DOI":"10.1021\/acsnano.8b02037","volume":"12","author":"Y Wang","year":"2018","unstructured":"Wang Y, Li L, Zhao W, Dou Y, An H, Tao H, Xu X, Jia Y, Lu S, Zhang J (2018b) Targeted therapy of atherosclerosis by a broad-spectrum reactive oxygen species scavenging nanoparticle with intrinsic anti-inflammatory activity. ACS Nano 12(9):8943\u20138960","journal-title":"ACS Nano"},{"issue":"7","key":"13007_CR176","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1093\/eurheartj\/ehy799","volume":"40","author":"Z Wang","year":"2019","unstructured":"Wang Z, Bergeron N, Levison BS, Li XS, Chiu S, Jia X, Koeth RA, Li L, Wu Y, Tang WW (2019) Impact of chronic dietary red meat, white meat, or non-meat protein on trimethylamine N-oxide metabolism and renal excretion in healthy men and women. Eur Heart J 40(7):583\u2013594","journal-title":"Eur Heart J"},{"issue":"2","key":"13007_CR177","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/s41591-020-01223-3","volume":"27","author":"DD Wang","year":"2021","unstructured":"Wang DD, Nguyen LH, Li Y, Yan Y, Ma W, Rinott E, Ivey KL, Shai I, Willett WC, Hu FB (2021a) The gut microbiome modulates the protective association between a Mediterranean diet and cardiometabolic disease risk. Nat Med 27(2):333\u2013343","journal-title":"Nat Med"},{"issue":"17","key":"13007_CR178","doi-asserted-by":"crossref","first-page":"5226","DOI":"10.1021\/acs.jafc.1c01463","volume":"69","author":"F Wang","year":"2021","unstructured":"Wang F, Zhao C, Yang M, Zhang L, Wei R, Meng K, Bao Y, Zhang L, Zheng J (2021b) Four citrus flavanones exert atherosclerosis alleviation effects in ApoE\u2013\/\u2013mice via different metabolic and signaling pathways. J Agric Food Chem 69(17):5226\u20135237","journal-title":"J Agric Food Chem"},{"issue":"4","key":"13007_CR179","doi-asserted-by":"crossref","first-page":"e0250126","DOI":"10.1371\/journal.pone.0250126","volume":"16","author":"Z Wang","year":"2021","unstructured":"Wang Z, Cheng C, Yang X, Zhang C (2021c) L-phenylalanine attenuates high salt-induced hypertension in Dahl SS rats through activation of GCH1-BH4. PLoS One 16(4):e0250126","journal-title":"PLoS One"},{"key":"13007_CR180","doi-asserted-by":"publisher","unstructured":"Wang ZC, Wu F, Zhou QB, Qiu YM, Zhang JN, Tu Q, Zhou Z, Shao YJ, Xu SY, Wang Y, Tao J (2022) Berberine improves vascular dysfunction by inhibiting trimethylamine-N-oxide via regulating the gut microbiota in angiotensin ii-induced hypertensive mice. Front Microbiol 13 https:\/\/doi.org\/10.3389\/fmicb.2022.814855","DOI":"10.3389\/fmicb.2022.814855"},{"issue":"2","key":"13007_CR181","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/s11684-021-0857-2","volume":"16","author":"H Wei","year":"2022","unstructured":"Wei H, Zhao M, Huang M, Li C, Gao J, Yu T, Zhang Q, Shen X, Ji L, Ni L, Zhao C, Wang Z, Dong E, Zheng L, Wang DW (2022) FMO3-TMAO axis modulates the clinical outcome in chronic heart-failure patients with reduced ejection fraction: evidence from an Asian population. Front Med-PRC 16(2):295\u2013305. https:\/\/doi.org\/10.1007\/s11684-021-0857-2","journal-title":"Front Med-PRC"},{"issue":"6427","key":"13007_CR182","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1126\/science.aav0558","volume":"363","author":"PJ White","year":"2019","unstructured":"White PJ, Newgard CB (2019) Branched-chain amino acids in disease. Science 363(6427):582\u2013583","journal-title":"Science"},{"issue":"7","key":"13007_CR183","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1080\/14728222.2020.1761958","volume":"24","author":"M Wijdeveld","year":"2020","unstructured":"Wijdeveld M, Nieuwdorp M, Ijzerman R (2020) The interaction between microbiome and host central nervous system: the gut-brain axis as a potential new therapeutic target in the treatment of obesity and cardiometabolic disease. Expert Opin Ther Tar 24(7):639\u2013653","journal-title":"Expert Opin Ther Tar"},{"issue":"6052","key":"13007_CR184","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1126\/science.1208344","volume":"334","author":"GD Wu","year":"2011","unstructured":"Wu GD, Chen J, Hoffmann C, Bittinger K, Chen Y-Y, Keilbaugh SA, Bewtra M, Knights D, Walters WA, Knight R (2011) Linking long-term dietary patterns with gut microbial enterotypes. Science 334(6052):105\u2013108","journal-title":"Science"},{"issue":"2","key":"13007_CR185","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1136\/gutjnl-2017-315458","volume":"68","author":"T-R Wu","year":"2019","unstructured":"Wu T-R, Lin C-S, Chang C-J, Lin T-L, Martel J, Ko Y-F, Ojcius DM, Lu C-C, Young JD, Lai H-C (2019) Gut commensal Parabacteroides goldsteinii plays a predominant role in the anti-obesity effects of polysaccharides isolated from Hirsutella sinensis. Gut 68(2):248\u2013262","journal-title":"Gut"},{"issue":"3","key":"13007_CR186","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.cmet.2020.06.011","volume":"32","author":"H Wu","year":"2020","unstructured":"Wu H, Tremaroli V, Schmidt C, Lundqvist A, Olsson LM, Kr\u00e4mer M, Gummesson A, Perkins R, Bergstr\u00f6m G, B\u00e4ckhed F (2020) The gut microbiota in prediabetes and diabetes: a population-based cross-sectional study. Cell Metab 32(3):379-390.e3","journal-title":"Cell Metab"},{"key":"13007_CR187","doi-asserted-by":"crossref","unstructured":"Wu Q, Sun L, Hu X, Wang X, Xu F, Chen B, Liang X, Xia J, Wang P, Aibara D (2021) Suppressing the intestinal farnesoid X receptor\/sphingomyelin phosphodiesterase 3 axis decreases atherosclerosis. J Clin Invest 131(9)","DOI":"10.1172\/JCI142865"},{"key":"13007_CR188","doi-asserted-by":"publisher","unstructured":"Wu L, Li M-Q, Xie Y-T, Zhang Q, Lu X-J, Liu T, Lin W-Y, Xu J-T, Wu Q-P, He X-X (2022a) Washed microbiota transplantation improves patients with high blood glucose in South China. Front Endocrinol 13 https:\/\/doi.org\/10.3389\/fendo.2022.985636","DOI":"10.3389\/fendo.2022.985636"},{"key":"13007_CR189","doi-asserted-by":"crossref","unstructured":"Wu L, Lu X-J, Lin D-J, Chen W-J, Xue X-Y, Liu T, Xu J-T, Xie Y-T, Li M-Q, Lin W-Y (2022b) Washed microbiota transplantation improves patients with metabolic syndrome in South China. Front Cell Infect MI 1713","DOI":"10.3389\/fcimb.2022.1044957"},{"issue":"4","key":"13007_CR190","doi-asserted-by":"crossref","first-page":"869","DOI":"10.21037\/cdt-20-428","volume":"10","author":"J Xu","year":"2020","unstructured":"Xu J, Yang Y (2020) Implications of gut microbiome on coronary artery disease. Cardiovasc Diagn The 10(4):869","journal-title":"Cardiovasc Diagn The"},{"issue":"1","key":"13007_CR191","doi-asserted-by":"crossref","first-page":"1936379","DOI":"10.1080\/19490976.2021.1936379","volume":"13","author":"J Xu","year":"2021","unstructured":"Xu J, Yang Y (2021) Gut microbiome and its meta-omics perspectives: profound implications for cardiovascular diseases. Gut Microbes 13(1):1936379","journal-title":"Gut Microbes"},{"issue":"3","key":"13007_CR192","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1039\/C8FO02163E","volume":"10","author":"S Yan","year":"2019","unstructured":"Yan S, Tian Z, Li M, Li B, Cui W (2019) Effects of probiotic supplementation on the regulation of blood lipid levels in overweight or obese subjects: a meta-analysis. Food Funct 10(3):1747\u20131759","journal-title":"Food Funct"},{"issue":"7","key":"13007_CR193","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1161\/CIRCRESAHA.119.316394","volume":"126","author":"X Yan","year":"2020","unstructured":"Yan X, Jin J, Su X, Yin X, Gao J, Wang X, Zhang S, Bu P, Wang M, Zhang Y, Wang Z, Zhang Q (2020) Intestinal flora modulates blood pressure by regulating the synthesis of intestinal-derived corticosterone in high salt-induced hypertension. Circ Res 126(7):839\u2013853","journal-title":"Circ Res"},{"issue":"5","key":"13007_CR194","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1093\/ajcn\/nqaa430","volume":"113","author":"JJ Yang","year":"2021","unstructured":"Yang JJ, Shu X-O, Herrington DM, Moore SC, Meyer KA, Ose J, Menni C, Palmer ND, Eliassen H, Harada S (2021b) Circulating trimethylamine N-oxide in association with diet and cardiometabolic biomarkers: an international pooled analysis. Am J Clin Nutr 113(5):1145\u20131156","journal-title":"Am J Clin Nutr"},{"issue":"30","key":"13007_CR195","doi-asserted-by":"publisher","first-page":"8448","DOI":"10.1021\/acs.jafc.1c02774","volume":"69","author":"WQ Yang","year":"2021","unstructured":"Yang WQ, Ren DY, Zhao Y, Liu L, Yang XB (2021d) Fuzhuan brick tea polysaccharide improved ulcerative colitis in association with gut microbiota-derived tryptophan metabolism. J Agric Food Chem 69(30):8448\u20138459. https:\/\/doi.org\/10.1021\/acs.jafc.1c02774","journal-title":"J Agric Food Chem"},{"issue":"24","key":"13007_CR196","doi-asserted-by":"crossref","first-page":"3609","DOI":"10.3748\/wjg.v27.i24.3609","volume":"27","author":"Z-H Yang","year":"2021","unstructured":"Yang Z-H, Liu F, Zhu X-R, Suo F-Y, Jia Z-j, Yao S-K (2021e) Altered profiles of fecal bile acids correlate with gut microbiota and inflammatory responses in patients with ulcerative colitis. World J Gastroentero 27(24):3609","journal-title":"World J Gastroentero"},{"issue":"5","key":"13007_CR197","doi-asserted-by":"publisher","first-page":"oeac021","DOI":"10.1093\/ehjopen\/oeac021","volume":"2","author":"Y Yang","year":"2022","unstructured":"Yang Y, Zeng Q, Gao J, Yang B, Zhou J, Li K, Li L, Wang A, Li X, Liu Z, Luo Q, Zhao Z, Liu B, Xue J, Jiang X, Konerman MC, Zheng L, Xiong C (2022) High-circulating gut microbiota-dependent metabolite trimethylamine N-oxide is associated with poor prognosis in pulmonary arterial hypertension. Eur Heart J Open 2(5):oeac021. https:\/\/doi.org\/10.1093\/ehjopen\/oeac021","journal-title":"Eur Heart J Open"},{"key":"13007_CR198","doi-asserted-by":"publisher","unstructured":"Yang G, Wei J, Liu P, Zhang Q, Tian Y, Hou G, Meng L, Xin Y, Jiang X (2021a) Role of the gut microbiota in type 2 diabetes and related diseases. Metabolism 117 https:\/\/doi.org\/10.1016\/j.metabol.2021.154712","DOI":"10.1016\/j.metabol.2021.154712"},{"key":"13007_CR199","doi-asserted-by":"publisher","unstructured":"Yang S, Li D, Yu Z, Li Y, Wu M (2021c) Multi-pharmacology of berberine in atherosclerosis and metabolic diseases: potential contribution of gut microbiota. Front Pharmacol 12 https:\/\/doi.org\/10.3389\/fphar.2021.709629","DOI":"10.3389\/fphar.2021.709629"},{"key":"13007_CR200","doi-asserted-by":"publisher","unstructured":"Yao Y, Yan L, Chen H, Wu N, Wang W, Wang D (2020) Cyclocarya paliurus polysaccharides alleviate type 2 diabetic symptoms by modulating gut microbiota and short-chain fatty acids. Phytomedicine 77 https:\/\/doi.org\/10.1016\/j.phymed.2020.153268","DOI":"10.1016\/j.phymed.2020.153268"},{"issue":"6556","key":"13007_CR201","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1126\/science.aba3683","volume":"373","author":"W Yoo","year":"2021","unstructured":"Yoo W, Zieba JK, Foegeding NJ, Torres TP, Shelton CD, Shealy NG, Byndloss AJ, Cevallos SA, Gertz E, Tiffany CR (2021) High-fat diet\u2013induced colonocyte dysfunction escalates microbiota-derived trimethylamine N-oxide. Science 373(6556):813\u2013818","journal-title":"Science"},{"key":"13007_CR202","doi-asserted-by":"publisher","unstructured":"Yoo JY, Sniffen S, McGill Percy KC, Pallaval VB, Chidipi B (2022) Gut dysbiosis and immune system in atherosclerotic cardiovascular disease (ACVD). Microorganisms 10(1) https:\/\/doi.org\/10.3390\/microorganisms10010108","DOI":"10.3390\/microorganisms10010108"},{"key":"13007_CR203","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1016\/j.neubiorev.2021.10.046","volume":"132","author":"B Yousefi","year":"2022","unstructured":"Yousefi B, Kokhaei P, Mehranfar F, Bahar A, Abdolshahi A, Emadi A, Eslami M (2022) The role of the host microbiome in autism and neurodegenerative disorders and effect of epigenetic procedures in the brain functions. Eurosci Biobehav R 132:998\u20131009. https:\/\/doi.org\/10.1016\/j.neubiorev.2021.10.046","journal-title":"Eurosci Biobehav R"},{"key":"13007_CR204","doi-asserted-by":"publisher","unstructured":"Yuan Q, Xin L, Han S, Su Y, Wu R, Liu X, Wuri J, Li R, Yan T (2021) Lactulose improves neurological outcomes by repressing harmful bacteria and regulating inflammatory reactions in mice after stroke. Front Cell Infect Mi 11 https:\/\/doi.org\/10.3389\/fcimb.2021.644448","DOI":"10.3389\/fcimb.2021.644448"},{"key":"13007_CR205","doi-asserted-by":"crossref","unstructured":"Yuan L, Li Y, Chen M, Xue L, Wang J, Ding Y, Zhang J, Wu S, Ye Q, Zhang S, Yang R, Zhao H, Wu L, Liang T, Xie X, Wu Q (2022) Antihypertensive activity of milk fermented by Lactiplantibacillus plantarum SR37-3 and SR61-2 in L-NAME-induced hypertensive rats. Foods 11(15) 10.3390\/foods11152332","DOI":"10.3390\/foods11152332"},{"key":"13007_CR206","doi-asserted-by":"publisher","unstructured":"Yukino-Iwashita M, Nagatomo Y, Kawai A, Taruoka A, Yumita Y, Kagami K, Yasuda R, Toya T, Ikegami Y, Masaki N, Ido Y, Adachi T (2022) Short-chain fatty acids in gut-heart axis: their role in the pathology of heart failure. J Pers Med 12(11) https:\/\/doi.org\/10.3390\/jpm12111805","DOI":"10.3390\/jpm12111805"},{"issue":"1","key":"13007_CR207","doi-asserted-by":"crossref","first-page":"eaax6208","DOI":"10.1126\/sciadv.aax6208","volume":"6","author":"S-L Zeng","year":"2020","unstructured":"Zeng S-L, Li S-Z, Xiao P-T, Cai Y-Y, Chu C, Chen B-Z, Li P, Li J, Liu E-H (2020) Citrus polymethoxyflavones attenuate metabolic syndrome by regulating gut microbiome and amino acid metabolism. Sci Adv 6(1):eaax6208","journal-title":"Sci Adv"},{"key":"13007_CR208","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.lfs.2019.05.031","volume":"229","author":"F Zhang","year":"2019","unstructured":"Zhang F, Yuan W, Wei Y, Zhang D, Duan Y, Li B, Wang X, Xi L, Zhou Y, Wu X (2019a) The alterations of bile acids in rats with high-fat diet\/streptozotocin-induced type 2 diabetes and their negative effects on glucose metabolism. Life Sci 229:80\u201392. https:\/\/doi.org\/10.1016\/j.lfs.2019.05.031","journal-title":"Life Sci"},{"issue":"10","key":"13007_CR209","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.3390\/nu11102291","volume":"11","author":"Z Zhang","year":"2019","unstructured":"Zhang Z, Mocanu V, Cai C, Dang J, Slater L, Deehan EC, Walter J, Madsen KL (2019b) Impact of fecal microbiota transplantation on obesity and metabolic syndrome\u2014a systematic review. Nutrients 11(10):2291","journal-title":"Nutrients"},{"issue":"3","key":"13007_CR210","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1089\/dna.2021.0345","volume":"41","author":"S Zhang","year":"2022","unstructured":"Zhang S, Liang Y, Li L, Chen Y, Wu P, Wei D (2022) Succinate: a novel mediator to promote atherosclerotic lesion progression. DNA Cell Biol 41(3):285\u2013291. https:\/\/doi.org\/10.1089\/dna.2021.0345","journal-title":"DNA Cell Biol"},{"issue":"6380","key":"13007_CR211","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1126\/science.aao5774","volume":"359","author":"L Zhao","year":"2018","unstructured":"Zhao L, Zhang F, Ding X, Wu G, Lam YY, Wang X, Fu H, Xue X, Lu C, Ma J (2018) Gut bacteria selectively promoted by dietary fibers alleviate type 2 diabetes. Science 359(6380):1151\u20131156","journal-title":"Science"},{"key":"13007_CR212","doi-asserted-by":"publisher","DOI":"10.1080\/10408398.2022.2045895","author":"YH Zhao","year":"2022","unstructured":"Zhao YH, Li MJ, Wang YN, Geng RX, Fang JJ, Liu Q, Kang SG, Zeng WC, Huang KL, Tong T (2022) Understanding the mechanism underlying the anti-diabetic effect of dietary component: a focus on gut microbiota. Crit Rev Food Sci. https:\/\/doi.org\/10.1080\/10408398.2022.2045895","journal-title":"Crit Rev Food Sci"},{"issue":"23","key":"13007_CR213","doi-asserted-by":"crossref","first-page":"2546","DOI":"10.3748\/wjg.v28.i23.2546","volume":"28","author":"L Zheng","year":"2022","unstructured":"Zheng L, Ji Y-Y, Wen X-L, Duan S-L (2022) Fecal microbiota transplantation in the metabolic diseases: current status and perspectives. World J Gastroentero 28(23):2546","journal-title":"World J Gastroentero"},{"issue":"2021","key":"13007_CR214","doi-asserted-by":"crossref","first-page":"679624","DOI":"10.3389\/fcimb.2021.679624","volume":"11","author":"HJ Zhong","year":"2021","unstructured":"Zhong HJ, Zeng HL, Cai YL, Zhuang YP, Liou YL, Wu Q (2021) He XX (2021) Washed microbiota transplantation lowers blood pressure in patients with hypertension. Front Cell Infect Mi 11(2021):679624","journal-title":"Front Cell Infect Mi"},{"issue":"7758","key":"13007_CR215","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1038\/s41586-019-1236-x","volume":"569","author":"W Zhou","year":"2019","unstructured":"Zhou W, Sailani MR, Contrepois K, Zhou Y, Ahadi S, Leopold SR, Zhang MJ, Rao V, Avina M, Mishra T, Johnson J, Lee-McMullen B, Chen S, Metwally AA, Tran TDB, Nguyen H, Zhou X, Albright B, Hong B-Y, Petersen L, Bautista E, Hanson B, Chen L, Spakowicz D, Bahmani A, Salins D, Leopold B, Ashland M, Dagan-Rosenfeld O, Rego S, Limcaoco P, Colbert E, Allister C, Perelman D, Craig C, Wei E, Chaib H, Hornburg D, Dunn J, Liang L, Rose SMS-F, Kukurba K, Piening B, Rost H, Tse D, McLaughlin T, Sodergren E, Weinstock GM, Snyder M (2019) Longitudinal multi-omics of host\u2013microbe dynamics in prediabetes. Nature 569(7758):663\u2013671. https:\/\/doi.org\/10.1038\/s41586-019-1236-x","journal-title":"Nature"},{"issue":"1","key":"13007_CR216","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1002\/ehf2.12552","volume":"7","author":"X Zhou","year":"2020","unstructured":"Zhou X, Jin MC, Liu L, Yu ZL, Lu X, Zhang H (2020) Trimethylamine N-oxide and cardiovascular outcomes in patients with chronic heart failure after myocardial infarction. Esc Heart Fail 7(1):189\u2013194. https:\/\/doi.org\/10.1002\/ehf2.12552","journal-title":"Esc Heart Fail"},{"issue":"24","key":"13007_CR217","doi-asserted-by":"crossref","first-page":"12580","DOI":"10.1039\/D1FO02040D","volume":"12","author":"M Zhou","year":"2021","unstructured":"Zhou M, Li D, Xie K, Xu L, Kong B, Wang X, Tang Y, Liu Y, Huang H (2021) The short-chain fatty acid propionate improved ventricular electrical remodeling in a rat model with myocardial infarction. Food Funct 12(24):12580\u201312593","journal-title":"Food Funct"},{"issue":"5","key":"13007_CR218","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1111\/apm.13038","volume":"128","author":"Y Zhu","year":"2020","unstructured":"Zhu Y, Li Q, Jiang H (2020) Gut microbiota in atherosclerosis: focus on trimethylamine N-oxide. Apmis 128(5):353\u2013366","journal-title":"Apmis"},{"issue":"7","key":"13007_CR219","doi-asserted-by":"crossref","first-page":"2100897","DOI":"10.1002\/mnfr.202100897","volume":"66","author":"Z Zhu","year":"2022","unstructured":"Zhu Z, Huang R, Liu W, Wang J, Wu S, Chen M, Huang A, Xie Y, Chen M, Jiao C (2022) Whole agrocybe cylindracea prevented obesity linking with modification of gut microbiota and associated fecal metabolites in high-fat diet-fed mice. Mol Nutr Food Res 66(7):2100897","journal-title":"Mol Nutr Food Res"},{"issue":"4","key":"13007_CR220","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1002\/ehf2.13989","volume":"9","author":"X Zong","year":"2022","unstructured":"Zong X, Fan Q, Yang Q, Pan R, Zhuang L, Tao R (2022) Phenylacetylglutamine as a risk factor and prognostic indicator of heart failure. ESC Heart Failure 9(4):2645\u20132653","journal-title":"ESC Heart Failure"}],"container-title":["Applied Microbiology and Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00253-024-13007-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00253-024-13007-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00253-024-13007-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T16:42:21Z","timestamp":1748364141000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00253-024-13007-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,20]]},"references-count":220,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["13007"],"URL":"https:\/\/doi.org\/10.1007\/s00253-024-13007-7","relation":{},"ISSN":["0175-7598","1432-0614"],"issn-type":[{"value":"0175-7598","type":"print"},{"value":"1432-0614","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,20]]},"assertion":[{"value":"6 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 December 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article does not contain any studies with human participants performed by any of the authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"156"}}